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ABSTRACT  
 
Fetal alcohol spectrum disorder (FASD) encompasses a range of conditions induced by 
prenatal alcohol exposure. Fetal alcohol syndrome (FAS) is the most severe of these 
conditions. FAS is characterised by discriminating facial features along with growth 
deficiencies and central nervous system abnormalities.   
 
FASD is a growing concern in South Africa, particularly in the Northern and Western 
Cape Provinces. In the Northern Cape, astounding prevalence rates of 122 and 73.8 per 
1000 school entry children have been established for the towns of De Aar and Upington 
respectively. 
 
Studies involving twin concordance research and animal models have indicated that there 
is a genetic influence contributing towards FAS susceptibility in individuals. FAS is 
considered a complex disease whereby both genetic and environmental factors interact in 
disease pathogenesis. For this reason a case-control study involving the investigation of 
appropriate candidate genes was conducted. 
 
The neuronal migration pathway in the developing brain is targeted by prenatal alcohol 
exposure. The astrotactin (ASTN) and reelin (RELN) genes were selected for investigation 
based on their fundamental role in neuronal migration. A FAS case-control study 
involving 45 cases and 112 controls was conducted on the Northern Cape Coloured 
population.  
 
Four single nucleotide polymorphisms (SNPs) including missense and non-coding 
variants were selected within ASTN and four missense SNPs were selected within RELN. 
The study aimed to determine the genotype and allele frequencies of the variants within 
the case and control groups and to assess whether any association between the gene 
variants and the predisposition to FAS existed. Statistical analyses indicated a significant 
genotypic association (P= 0.049) between RELN’s rs607755 marker; the C/T genotype 
was more likely to be found amongst controls thus inferring a possible protective effect 
 v 
against FAS. A logistic regression model supported the above association by indicating 
the C/T genotype as being independently significant (P= 0.026).    
 
The most limiting factor of this study was the small sample size and consequent lack of 
power to detect genes with minor effects. It would therefore be suggested that the study be 
repeated once a larger sample size has been established. A larger sample size would 
increase the chances of detecting true associations between genes of minor effect and 
FAS, thus minimising false-positive associations from arising.  
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CHAPTER 1: INTRODUCTION 
 
1.1 FETAL ALCOHOL SYNDROME  
 
1.1.1 An Overview 
  
The term “fetal alcohol syndrome” (FAS) was first used in 1973 by Jones and colleagues 
whilst studying the offspring of severely alcoholic mothers (Jones et al.  1973). This 
however, was not the first study conducted on children of alcoholic mothers. In France, 
five years prior to the work carried out by Jones et al., Lemoine and colleagues performed 
a similar study and observed the same dysmorphic symptoms in the offspring of alcoholic 
mothers (reviewed in Viljoen, 1991). 
 
Growth retardation, central nervous system (CNS) damage and distinguishing craniofacial 
features are the most commonly reported abnormalities associated with FAS (Viljoen, 
1999; Warren and Li, 2005). Alcohol is referred to as a “teratogen” as it has the ability to 
cause birth defects (Goodlett and Horn, 2001). Of all the features of FAS, the 
teratogenicity of in utero alcohol exposure on the developing central nervous system 
appears to be the most severe and permanent and thus, consumption of alcohol by 
pregnant mothers has been described as being the most common cause of nonhereditary 
mental retardation amongst several communities worldwide. In South Africa, FAS is a 
severe and escalating problem (Viljoen, 1991; Viljoen, 1999). 
 
Ethanol can freely cross the placenta, which results in the blood alcohol levels of the fetus 
being comparable to those of the mother (Thomas and Riley, 1998). Knowledge about the 
mother’s drinking habits is of importance during diagnosis and the severity of the disease 
is proportional to the amount of alcohol consumed. No ‘safe’ level of drinking during 
pregnancy has been reported. Pregnant women are advised to abstain from all alcohol 
throughout the nine months of pregnancy (Viljoen, 1991). An average of more than one 
drink (0.5 oz) per day or in the case of binge drinking, more than five drinks per 
occurrence, has been described as being potentially harmful to an unborn fetus (Sokol et 
al. 2003). 
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Binge drinking has been shown to be more damaging towards the CNS than drinking a 
constant amount of alcohol over a long time span. Binge drinking results in a rapid 
increase in blood alcohol levels as opposed to a gradual increase seen with constant 
drinking over a long period of time (reviewed in Guerri, 2002). 
 
Heavy drinking has been described as being six or more drinks or more than 100 ml of 
absolute alcohol per day (Viljoen, 1991). It is well recognised that heavy alcohol 
consumption at any time during a pregnancy can cause serious problems involving CNS 
development and cognitive functioning.  
 
FAS is a severe and irreversible disease, which reduces the chances of the individual 
leading a normal life. Serious social and medical implications arise from FAS. Affected 
individuals have learning disabilities and are therefore compromised with regards to 
education. The disease itself can pose huge expenses upon the state in the form of medical 
care, special educational support and lost productivity. One of the most recent cost 
estimates from a National Institute on Drug Abuse (NIDA) and National Institute on 
Alcohol Abuse and Alcoholism (NIAAA) study indicated that the cost of FAS to the 
United States was more than $4 billion in 1998. It was also estimated that the lifetime cost 
for each affected individual was $2 million in the year 2002 (Lupton et al.  2004). In 
South Africa the effective costs would be lower since medical services and remedial 
education are not available for the majority of affected individuals.   
 
Certain studies have focused on the adverse life outcomes that occur amongst individuals 
affected by prenatal alcohol exposure. Drug and alcohol abuse appear to be problematic 
amongst FAS individuals. Another well documented adverse life outcome is disruptive 
and criminal behaviour. Individuals prenatally exposed to alcohol tend to be disorderly in 
a schooling environment and often find themselves in trouble with the law (Chaudhuri, 
2000).  
 
Studies like those mentioned above emphasise the importance of an early diagnosis when 
prenatal alcohol exposure has occurred in order to effectively cater and care for the 
affected child’s needs (Streissguth et al.  2004). Not only is FAS a severe medical 
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concern, it is a social one too (Chaudhuri, 2000) that requires early health education and 
intervention. A sound knowledge of the diagnostic criteria and a better understanding of 
the molecular basis of the disease can together help manage and hopefully prevent 
increasing numbers of cases worldwide. 
 
1.1.2 Clinical Features 
 
The severity of clinical symptoms following prenatal alcohol exposure can differ 
significantly based on the amount of alcohol consumption and the gestational timing at 
which the alcohol was consumed. The differences in these two factors can result in 
varying degrees of clinical manifestations. Fetal alcohol syndrome is the most severe of 
fetal alcohol diagnoses which all fall under the broader term of fetal alcohol spectrum 
disorder (FASD). In 1978 researchers suggested that drinking during the month preceding 
recognition of pregnancy appeared to produce the most significant relationship between 
maternal alcohol consumption and adverse fetal outcome (Hanson et al.  1978).  
 
Heavy drinking during the first trimester of pregnancy affects the facial and structural 
features of the unborn fetus; drinking during the second trimester appears to increase the 
rates of spontaneous abortions and third trimester drinking has a significant effect upon 
growth. However, because the brain is continuously developing throughout the gestation 
period, drinking at any time during pregnancy can cause neurodevelopmental, intellectual 
and behavioural abnormalities (reviewed in May et al.  2004).  
 
Clinically, FAS presents with distinct morphological abnormalities involving the head, 
face, limbs and other organs such as the heart, liver and eyes. Growth and varying degrees 
of mental retardation are other major defining characteristics of the disease (Jones et al. 
1973; Chaudhuri, 2000).  
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1.1.2.1 Growth Deficiency 
 
Pre and postnatal growth deficits are widely observed in children exposed to alcohol in 
utero. Height and weight are discriminating factors as well as head circumference. FAS 
individuals tend to be below the tenth percentile for any measurement regarding weight, 
height and head circumference for gestational age (Kvigne et al.  2004). Microcephaly is a 
distinguishing feature of FAS, whereby the head circumference is below the norm for the 
individuals’ age. Microcephaly is indicative of deficient brain growth (Clarren and Smith, 
1978).  
 
1.1.2.2 Central Nervous System Dysfunction 
 
The developing CNS is highly sensitive and vulnerable to the harmful effects of alcohol. 
Of all the classic features, mental retardation is the most consistent and detrimental factor 
of FAS even though the degree to which it occurs can vary. In 1980, it was reported that 
FAS is the third most common disorder in which mental retardation is a principle factor 
(Shaywitz et al.  1980). An overall lowering of intelligence is commonly reported in those 
affected with a mean intelligence quotient (IQ) of 65 (Clarren and Smith, 1978; Viljoen, 
1999). 
 
Along with a below average IQ, FAS children are inclined to have behavioural problems, 
developmental delays, speech and language impediments and learning disabilities. The 
neuropsychological implications of prenatal alcohol exposure are described in more detail 
later on in this chapter. With regards to behaviour, FAS children are usually hyperactive 
with short attention spans and commonly suffer from attention deficit disorder (Kvigne et 
al.  2004). Adolescents and adults with FAS regularly demonstrate poor socialisation and 
communication skills (Mattson et al.  2001).  
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1.1.2.3 Facial Dysmorphism 
 
The facial abnormalities are the most pronounced indicators of the disease; typically the 
middle third of the face is affected. A classic case would present with narrow palpebral 
fissures (eye openings), a long upper lip with an indistinct philtrum (groove between the 
top lip and the nose) and a thin vermilion border, epicanthic folds (skin folds over the 
eyes), a flattened nasal bridge and a short upturned nose as well as micrognathia 
(abnormal smallness of the jaw, especially of the mandible) (Viljoen, 1999). There are 
varying degrees of the clinical features in individuals and in particular, the severity of the 
facial features tend to diminish with increased age (Chaudhuri, 2000). Figure 1.1 
illustrates the diagnostic facial features as well as other associated facial features of FAS. 
 
 
Figure 1.1: The typical facial features associated with fetal alcohol syndrome (taken from 
Minnesota Department of Health website). 
 
 
 
 
 
 
1.1.2.4 Other Anomalies of FAS 
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Although not always observed, cardiac, skeletal and other organ manifestations have 
frequently been reported in FAS subjects (Kvigne et al.  2004). Cleft lip and palate, neural 
tube defects, genital abnormalities, renal and liver defects, heart murmurs, fifth finger 
hypoplasia, abnormal palmer creases especially a “hockey stick” configuration of the 
upper palmer crease and a variety of radiological alterations are some of the numerous 
minor deficits resulting from exposure to alcohol prenatally (Clarren and Smith, 1978).  
 
1.1.3 Diagnostic Criteria of FAS 
 
The diagnosis of FAS is easier to make when an individual is between the ages of four and 
fourteen years than at other ages. It is during these years that the features of FAS are most 
apparent. FAS diagnosis on newborns or adults is more complicated, as the features are 
either under developed (newborns) or have disappeared or become less distinct (adults) 
(Lupton et al.  2004).  
 
Diagnosis of fetal alcohol syndrome is based upon three major proposed criteria (Sokol 
and Clarren, 1989). The diagnostic criteria are as follows: 
1. Prenatal and/or postnatal growth deficiency (weight or length or both, below 
the tenth percentile for the gestational age). 
2. Central nervous system irregularities, including developmental delays, 
neurological problems, intellectual impairment and structural abnormalities. 
3. Characteristic facial features including short palpebral fissures, a thin upper lip 
and an elongated, flattened midface as well as an indistinct philtrum.  
 
Together with the existence of the above features, confirmation of heavy maternal 
drinking (more than 90-100 mg of absolute alcohol per week) during pregnancy should 
ideally be obtained in order to make a successful diagnosis of FAS (Viljoen, 1999). Table 
1.1 illustrates the necessary characteristics required for a sound diagnosis of FAS. 
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Table 1.1: Centers for Disease Control criteria for the diagnosis of FAS with confirmed or 
unknown maternal drinking history (modified from Welch-Carre, 2005) 
 
Facial Features Growth Deficiencies CNS Abnormalities 
 
All 3 must be present:  Must have 1 of the following: 
 
• Smooth philtrum 
• Thin vermilion 
• Small palpebral 
fissures  
Height, weight, or both, 
at or below the 10th 
percentile, documented 
at any one point in 
time. 
1. Structural 
Head circumference at or below 
the 10th percentile, adjusted for 
age and sex. 
 
2. Neurological  
Neurological problems not due 
to postnatal insult or fever, or 
other soft neurological sign 
outside normal limits. 
 
3. Functional 
Below average performance as 
evidenced by: 
Global cognitive or intellectual 
deficits representing multiple 
domains of deficit with 
performance below the 3rd 
percentile. Functional deficits 
below the 16th percentile in at 
least 3 of the following areas: 
• Cognitive or 
developmental deficits 
• Executive functioning 
deficits 
• Motor functioning 
delays 
• Problems with attention 
and hyperactivity 
• Social skills 
• Sensory problems, 
language and memory 
deficits 
 
 
 
 
                                                                                                                                                INTRODUCTION                                       
 8 
1.1.3.1 Additional Terminology 
 
Fetal alcohol spectrum disorder (FASD) is a term encompassing all conditions arising 
from prenatal alcohol exposure. Fetal alcohol syndrome falls at the severe end of the 
spectrum (Hoyme et al.  2005). Not all episodes of drinking during pregnancy result in 
full-blown FAS affected infants. There are other categories a child can be classified into 
depending on which features are or are not present. As defined by the Institute of 
Medicine (IOM), 1996, FASD refers collectively to FAS, partial FAS, alcohol related 
birth defects (ARBD) and alcohol related neurodevelopmental disorder (ARND) 
(Jacobson and Jacobson, 2002). 
 
Partial FAS is used to describe children who display some of the facial features of FAS as 
well as some of the physical growth or neurodevelopmental abnormalities. ARBD is a 
term used to describe an individual with confirmed maternal drinking during pregnancy 
who has some of the structural organ abnormalities associated with prenatal alcohol 
exposure such as cardiac, renal and skeletal defects. ARND refers to children who have 
confirmed prenatal alcohol exposure but do not have the phenotypic criteria necessary for 
a FAS diagnosis; instead they display neurodevelopmental deficiencies typical to FAS 
children (Jacobson and Jacobson, 2002). 
 
1.1.4 Other Maternal Risk Factors 
 
It is clearly understood that heavy drinking during pregnancy is the primary risk factor for 
FAS. However, the pattern of drinking, especially heavy episodic (binge) drinking is 
particularly associated with the disease (May et al.  2004). Based on studies carried out on 
mothers of FAS children, other maternal risk factors have been pinpointed in association 
with the high prevalence rate of FAS in certain populations.  
 
A study carried out by Viljoen et al. (2000) focused on mothers of FAS children from a 
community of relatively low socioeconomic status in the Western Cape of South Africa. 
Mothers of FAS children had heavier drinking patterns, began consuming alcohol at an 
earlier age and had higher rates of drinking and alcohol abuse within their extended 
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families when compared to control mothers. It appeared as though the majority of mothers 
of FAS children had mothers themselves (maternal grandmothers to FAS children) who 
drank heavily. This differed significantly from the control group where maternal 
grandmothers were considered “non-drinkers” or “light drinkers.”  
 
Tobacco smoking during pregnancy was far higher in case mothers compared to control 
mothers. Besides these factors, this study found significant differences between the case 
and control individuals regarding education and religiosity. Mothers of FAS children had 
received notably less formal education, calculated to be about 28% less than control 
mothers and were less involved in religious practices such as church attendance and 
prayer (Viljoen et al.  2002). 
 
Kvigne et al. (2003) carried out a study in the United States, on Northern Plains Indian 
mothers of FAS children. Like the results generated by Viljoen et al. (2002), this 
investigation also illustrated that the mean educational level of case mothers was 9.8 years 
which was significantly lower than the 11.0 years calculated for control mothers. Case 
mothers in this investigation had far higher rates of heavy drinking compared to control 
mothers. Furthermore, most case grandmothers had alcohol use documented in their 
medical records whereas only one half of control grandmothers had alcohol use recorded 
in their files.  
 
Kvigne et al. (2003) also found that mothers of FAS children were slightly older than the 
control mothers. In addition to the other findings the investigators found that within 
medical records, case mothers had mental health problems, especially depression, injuries 
(including alcohol related ones), sexual abuse and alcohol related problems, such as 
cirrhosis, recorded significantly more often than in the medical records of control mothers 
(Kvigne et al.  2003). 
 
May et al. (2004) indicated that maternal age at time of pregnancy is definitely a variable 
of maternal risk for FAS. Older women, classified by Viljoen et al. (2001) as being greater 
than 27 years, are at higher risk of producing FAS children, which could be linked to more 
years of drinking compared to younger women. It has also been suggested that nutrition 
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and body size (Body Mass Index (BMI)) could be important risk factors for FAS. The 
poorer the nutrition of the individual, the lower their body size and therefore BMI. 
Smaller individuals have less body mass to assist in metabolising the consumed alcohol, 
which might make them more susceptible to producing FAS offspring (May et al.  2004).    
 
These studies illustrate that certain social and maternal factors have been seen to 
accompany the presence of FAS within a family. Sufficient education seems to be a key 
factor that is lacking in mothers of FAS children and this probably goes hand-in-hand with 
low socioeconomic status. Poor nutrition and small body mass are possibly closely 
associated with poorer living conditions due to low socioeconomic status.  Living within a 
family that drinks heavily, especially having a mother that drinks, appears to negatively 
influence the drinking habits of mothers with FAS children in that they are more likely to 
start drinking at an early age and become heavy drinkers themselves. 
 
 
1.2 ALCOHOL CONSUMPTION IN SOUTH AFRICA  
 
In certain regions of South Africa, especially in wine-growing areas, alcohol abuse and 
consequently FAS, is a severely escalating problem. Studies conducted in South Africa 
have focused on the Western and Northern Cape Provinces as well as the Gauteng 
Province (Croxford and Viljoen, 1999). 
 
The Western Cape, in particular, is renowned for its grape-growing and wine production 
and most reports on alcohol consumption and FAS have focused on communities within 
this province. The predominant ethnic group of the Western Cape is Coloured, a 
population that arose over 300 years ago from admixture between the original local 
inhabitants, the Khoisan, and colonisers of European decent as well as local black 
Africans that originally migrated from Central Africa (Viljoen et al.  2001). The 
demographics for the Western Cape Province population in the year 2000 were 57% 
Coloured, 18% Black, 24% White and 1% other (May et al.  2000). Alcohol consumption 
and FAS prevalence are relatively high amongst the Coloured population (Viljoen et al.  
2001).  
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Traditionally, farm workers were partially paid for their labour in the form of wine, which 
was consumed daily. This method of part remuneration of farm labourers was known as 
the “dop” system (May et al.  2000). Despite being outlawed today, the origins of 
excessive alcohol consumption and abuse amongst farm workers of wine-growing regions, 
have their roots in the fore mentioned “dop” system. Alcohol still appears to be valued 
and favoured, and problematic drinking behaviour is widespread amongst the local 
population of workers (Viljoen et al.  2002). 
 
Along with the legacy of the “dop” system, another attribute to excessive alcohol 
consumption in certain regions within South Africa is the ease at which alcohol can be 
obtained. Accessibility to alcohol has increased in the form of illegal, informal bars 
known as “shebeens” where cheap and inferior quality alcohol can be purchased (May et 
al.  2000).  
 
A study carried out in the year 2000 reported 87% of farm workers in the Western Cape 
region as being problem drinkers. For many communities in South Africa where poverty 
is prevalent and where drinking is customary, alcohol is still a major form of recreation 
(Viljoen et al.  2002). 
 
1.2.1 FAS Prevalence: South Africa versus Other Countries   
 
One of the early reports on FAS in South Africa was written in 1978, where four infants 
born to alcoholic mothers in Cape Town were examined and clinical features consistent 
with those reported a few years earlier by Jones et al. (1973) were noted (Beyers and 
Moosa, 1978). FAS has therefore been reported in South Africa for a number of years but 
it was not until May et al. (2000) carried out an epidemiological study that the actual 
prevalence of the disease was noted.  
 
The United States prevalence rate for FAS ranges from 0.5 - 2.0 per 1000 births (May et 
al.  2004). Other studies have investigated the prevalence of FAS in various regions of 
certain countries. A study carried out in Roubaix, France, indicated an estimated incidence 
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of 2.3 per 1000 births and two studies conducted in Stockholm and Göteborg, Sweden, 
revealed 2.51 and 1.61 per 1000 births estimates respectively (Sampson et al.  1997).   
 
An investigation into alcohol consumption by pregnant women in three regions of the 
Western Cape revealed that 42.8% of pregnant women attending antenatal clinics 
admitted to consuming alcohol during their pregnancy which indicated that the FAS 
incidence in this province was expected to be high (Croxford and Viljoen, 1999). In the 
year 2000, May et al. reported a community of low socioeconomic status in the Western 
Cape Province of South Africa as having the highest reported prevalence rate of FAS 
worldwide, a rate of 39.2 – 46.4 per 1000 births (May et al.  2000).  
 
Research undertaken by the Foundation for Alcohol Related Research (FARR) in South 
Africa has indicated that the FASD prevalence rate in Wellington, a town in the Western 
Cape, is actually rising each year. The rates of FASD were established in school entry 
children during the years 1997, 1999 and 2001. Rates of 46, 75 and 88 per 1000 children 
were reported for the respective years (Viljoen, 2005). These studies illustrate the effects 
of the drinking patterns developed amongst communities within the wine-growing 
regions; alcohol consumption is severely high and as a result FAS is endemic. 
 
The FAS prevalence rates mentioned above are exceptionally high. However, researchers 
were unsure whether the rate amongst other communities of low socioeconomic status in 
South Africa would indicate similar findings or whether the results were exclusively 
associated with the wine-growing regions of the Western Cape (Centers for Disease 
Control, 2003). Therefore, in 2001, a study was conducted on four communities around 
Johannesburg in the Gauteng Province where wine production is absent. Methods similar 
to those employed in the Western Cape study were used and results revealed a FAS 
prevalence rate of 19 per 1000. Despite not being as high as the rate obtained for the 
Western Cape, 19 per 1000 births is still extremely high when compared to figures from 
the rest of the world. This study emphasised that although FAS is endemic amongst some 
communities in the wine-growing regions it is not exclusive to them; instead it appears to 
be a serious public health problem in South Africa (Centers for Disease Control, 2003). 
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Currently studies are underway in the Northern Cape Province of South Africa, 
particularly in the towns of Upington and De Aar where FAS is significantly present. The 
majority of the inhabitants of these areas are also Coloured with some Black individuals 
and a few White residents. Even though grape-growing and wine production is not as 
prevalent as in the Western Cape, the majority of the inhabitants in these two towns are 
poverty stricken and culturally alcohol plays a major role in recreation. An astounding 
FASD prevalence rate of 122 per 1000 school entry children has been established for the 
town of De Aar, the highest rate ever reported. The Upington epidemiology study has 
revealed a prevalence rate of 73.8 per 1000 school entry children (Viljoen, 2005). 
 
The photographs seen in figure 1.2 were taken as part of the Northern Cape De Aar 
project. The extent to which FAS is found within one South African family is illustrated in 
(a), the three children standing in the photo were all diagnosed with FAS. According to 
the mother, she stopped drinking during her pregnancy with the fourth child (seen in her 
arms), however, this child did not fall within the study group and was therefore not 
examined for an accurate diagnosis to be made. The front view and profile of one of the 
affected children indicating the facial features of FAS can be seen in (b) and (c) 
respectively. 
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Figure 1.2: An index family from the De Aar FAS study in the Northern Cape. All three 
children standing are affected with FAS, the mother admitted to dinking throughout all 
three pregnancies (a). The front (b) and side (c) profiles of one of the FAS affected 
children. Some discriminating facial features include a long smooth upper lip and smooth 
philtrum as well as short palpebral fissures. Note the flattened nasal bridge and relatively 
small mandible (photos courtesy of Leigh-Anne Fourie, FARR, with permission from the 
family). 
 
 
 
 
 
b c 
a 
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1.3 NEUROLOGICAL EFFECTS OF PRENATAL ETHANOL EXPOSURE 
 
Human gestation is separated into two main phases, the embryonic stage, which is up to 
eight weeks of gestation, and the fetal stage, which is from eight weeks up until birth. It is 
during the embryonic period in particular that abnormalities are readily induced by certain 
drugs within the mother’s bloodstream or through her diet (Michaelis and Michaelis, 
1994).  
 
During embryological and fetal development different organs develop intermittently 
(figure 1.3). As described previously, agents that are able to cause birth defects are 
referred to as teratogens. Most teratogens tend to be selective as to which organs they 
affect. This selectivity is dependent upon factors such as timing of exposure of the embryo 
to the teratogen, the quantity of the teratogen taken by the pregnant mother and the 
sensitivity of each developing organ’s cells to the harmful effect of the teratogen 
(reviewed in Michaelis and Michaelis, 1994). 
 
Based on figure 1.3, the heart starts developing from the middle of the third week up until 
the end of the eighth week. It is from the middle of week three until the middle of week 
six that the heart is most sensitive to the effects of teratogens. From the middle of week 
six until the end of week eight the heart is still undergoing development but should it be 
exposed to teratogens during this period, physiological and minor as opposed to major 
anomalies would persist. 
 
The CNS on the other hand develops throughout the nine months of pregnancy and is 
therefore constantly vulnerable to the harmful effects of teratogens, such as alcohol, over 
the full 38 weeks. The human developing brain undergoes a rapid surge of growth during 
the third trimester and it is during this period that the brain is especially susceptible to 
ethanol-induced damage resulting in microcephaly and behavioural deficits (reviewed in 
Guerri, 2002). Based on figure 1.3, from week three up until the end of week sixteen the 
CNS is particularly sensitive and any insult during this period would result in major 
structural irregularities. After week sixteen and up until the end of gestation, the CNS is 
prone to physiological and minor structural problems (table 1.2).  
                                                                                                                                                INTRODUCTION                                       
 16 
Heavy and frequent alcohol consumption during the first trimester has been shown to 
predominantly affect the facial and structural features whereas drinking during the third 
trimester has an adverse effect on growth (May et al.  2004). It is therefore not surprising 
that maternal alcohol ingestion during any time of pregnancy can be detrimental to the 
unborn child. 
  
 
Figure 1.3: The various stages of organ development and the critical periods at which the 
fetus is most susceptible to birth defects induced by teratogens. Red denotes the highly 
sensitive periods where major defects may be produced. Yellow indicates the stages that 
are less sensitive to teratogens and where minor defects may be induced (taken from 
Moore and Persaud, 1993). 
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1.3.1 Areas of the Brain Susceptible to Alcohol Induced Damage 
 
Damage caused to the developing brain by prenatal alcohol exposure is serious and 
permanent. The neurological effects are irreversible and will remain throughout a person’s 
life (Chaudhuri, 2000). Autopsy reports and neuroimaging techniques such as magnetic 
resonance imaging (MRI) and single photon emission computed tomography (SPECT) 
have helped researchers understand the structural abnormalities of the brain caused by 
prenatal alcohol exposure. These findings have in turn lent some insight into what 
neuropsychological and behavioural problems manifest as a result of the structural 
changes (Clarren et al.  1978). 
  
The areas of the brain most vulnerable to alcohol’s toxicity are illustrated in figure 1.4. 
Most investigations have focused on the corpus callosum, cerebellum, basal ganglia and 
hippocampus (Mattson et al.  2001). The frontal lobes and hypothalamus have also been 
viewed as being sensitive areas to alcohol’s teratogenicity (Kellerman, 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4: The areas of the brain most seriously affected by prenatal alcohol exposure 
(Kellerman, 2003). 
  
The corpus callosum is a mass of intertwined nerve fibres that connects the two 
hemispheres of the brain. It is responsible for passing information from side to side with 
the right side controlling impulse and feelings while the left side governs logic. 
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Abnormalities in the corpus callosum have negative effects on attention span, reading, 
verbal and learning abilities and overall intellectual performance (Mattson et al.  2001). 
 
The basal ganglia are a group of nerve cell clusters found deep within the white matter of 
the cerebrum. Within these clusters the caudate nucleus, putamen and globus pallidus can 
be found. These three sub-structures are involved in spatial memory, perception and 
thinking. The caudate nucleus in particular governs some advanced cognitive functions 
such as the ability to switch modes, planning ahead and problem solving (Mattson et al.  
2001; NIAAA, 2000). 
 
The cerebellum is located at the base of the brain and is especially affected by prenatal 
alcohol exposure. This region is involved in motor and cognitive skills such as attention as 
well as balance and co-ordination. Damage to this area of the brain has been coupled with 
learning problems as well as balance and co-ordination concerns (Mattson et al.  2001; 
NIAAA, 2000). 
 
The key function of the hippocampus is consolidation of memories and any insult on this 
region would result in deficits in memory functions such as the ability to store new 
memories (Mattson et al.  2001). The fontal lobes oversee decision making and impulses. 
The prefrontal cortex is responsible for controlling the executive functions such as 
problem solving, regulation of emotion, motivation and inhibition. The hypothalamus 
rules temperature as well as the feeling of pain and appetite (Kellerman 2003).  
 
1.3.2 Structural Damage 
 
One of the diagnostic characteristics of FAS is microcephaly, which means ‘small head,’ 
one that has a circumference at or below the tenth percentile (table 1.1). Microcephaly is 
nearly always associated with an abnormally undersized brain, most often referred to as 
micrencephaly. The overall size of a FAS brain is usually significantly reduced compared 
to an unaffected brain (figure 1.5) making micrencephaly a considerably common finding 
(Clarren et al.  1978). 
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Studies on the brains of FAS individuals have revealed that damage is extensive and 
involves irregularities in the formation of the actual brain tissue itself, both the grey as 
well as the white matter regions are affected (Archibald et al.  2001). The cortex of the 
brain is composed of grey matter, which consists of nerve cell bodies, dendrites, and 
axons that are not surrounded by a myelin sheath. Grey matter actually appears grey in 
colour. White matter on the other hand consists of myelinated nerve fibres (the axons) 
which connect nerve cells with each other; the myelin sheaths give this tissue a white 
appearance (Mattson et al.  2001; Campbell et al.  1999). 
 
Postmortem studies of FAS brains have reported cerebral and cerebellar disorganisation 
with strange arrangements of neurons in the cortex. Another interesting finding that has 
been documented in a number of FAS cases is the presence of neuroglial heterotopias 
which are abnormal neural and glial tissue covering segments of the brain surface (Clarren 
et al.  1978). 
 
The corpus callosum is an area of the brain that has often been reported as being 
malformed in studies involving MRI, SPECT and autopsies on FAS individuals. 
Hypoplasia (underdevelopment), as well as partial to complete agenesis (absence) of the 
corpus callosum has been documented in a number of FAS cases (Swayze et al.  1997). 
Reduction in the basal ganglia and cerebellum volume have also been seen within FAS 
brains (Archibald et al.  2001). Cortical atrophy (degeneration), delayed myelination of 
the white matter (Riikonen et al.  1999) and hydrocephaly (Clarren et al.  1978) are other 
features that have been documented in FAS individuals. 
 
The FAS brain in figure 1.5 is a particularly severely affected one. As mentioned 
previously the degree of FASD in a child, and therefore the structural damage caused by 
alcohol to the child’s brain, can vary depending on factors such as alcohol dosage and 
time during pregnancy at which alcohol was consumed (Clarren et al.  1978). One cannot 
then assume that all FAS affected individuals’ brains physically appear like the one 
presented in figure 1.5 as there is no specific pattern of brain damage and the extent of the 
abnormalities is not consistent in all FAS cases (NIAAA, 2000). One can however 
confidently say that the brain is most definitely targeted by alcohol and causes varying 
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degrees of physical abnormalities and as a consequence, psychological problems in a 
child. 
 
Figure 1.5: The difference in size and structure between the brain of a six week old FAS 
child and an unaffected child of the same age (Kellerman, 2003). 
 
1.3.3 Neuropsychological Impairments 
 
FAS individuals tend to exhibit cognitive and fine and gross motor performance 
impairments. The various areas of performance that are affected are discussed below: 
 
1.3.3.1 Learning and Memory 
 
Studies performed on FAS individuals have indicated that they show impairment in 
certain areas of memory. In particular these people tend to have difficulty in learning new 
information (Mattson et al.  2001). With regards to memory, studies have highlighted that 
retention and recognition memory are relatively unaffected in most FAS cases but 
declarative memory, whereby individuals have to give verbal feedback on a previously 
learnt task is often impaired (Jacobson and Jacobson, 2002). Based on the various 
functions of the different regions in the brain that are most susceptible to alcohol damage 
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(figure 1.4), impairments in learning and memory are indicative of damage to the 
cerebellum and hippocampus respectively (Mattson et al.  2001).  
 
1.3.3.2 Executive Functioning 
 
Executive functioning encompasses all higher level cognitive skills such as the ability to 
plan ahead, solve problems and think conceptually. Children exposed to alcohol prenatally 
usually have executive functioning deficits that can cause negative impacts on their lives. 
Individuals with prenatal alcohol exposure are more likely to act on impulse instead of 
first considering what consequences their actions might entail and they also exhibit 
difficulty in problem solving and planning ahead. It is evident that any individual 
experiencing problems such as the ones mentioned would more than likely struggle in a 
mainstream schooling environment as they would require special attention and extra help 
(Mattson et al.  2001). Impairments in the mentioned executive functioning activities 
indicate damage to the frontal lobes of the brain, particularly to the prefrontal cortex 
(Kellerman, 2003). 
 
1.3.3.3 Motor Control 
 
Motor control involves feedback from the body’s peripheral nervous system, involving 
sensory organs such as the eyes and ears, to the CNS. The vestibular system is located in 
the inner ear and is also important in motor control as it controls one’s sense of balance. 
Tests on children exposed to alcohol prenatally have revealed abnormalities in the 
development of motor control. It has also been suggested that balance problems in these 
individuals could possibly be attributable to direct deficits of the CNS as opposed to the 
peripheral nervous system (NIAAA, 2000). Direct damage to the cerebellum is 
responsible for balance deficits (Mattson et al.  2001). 
 
 
 
 
 
                                                                                                                                                INTRODUCTION                                       
 22 
1.3.3.4 Psychosocial and Behavioural Discrepancies  
 
Various studies have indicated that children exposed to alcohol prenatally experience 
behavioural problems that can be disruptive in their homes, schools and social 
environments. Behaviour wise, attention deficits and hyperactivity have been associated 
with alcohol exposure in children (Mattson et al.  2001). Riikonen et al. (1999) reported 
an interesting finding when examining the brains of ten FAS subjects through MRI and 
SPECT. Normal left-right dominance was lacking in the frontal area of the brain. This is 
the area of the brain that is affected in attention deficit hyperactivity disorder (ADHD).  
 
Psychiatric disorders and antisocial behaviour are common amongst children exposed to 
alcohol. Their socialisation and communication skills tend to be poor and depression and 
anxiety have been documented in a number of subjects. The behaviour of children 
prenatally exposed to alcohol has been documented as being characteristic of people with 
autism in that they exhibit deficits in social relations and communication (NIAAA, 2000). 
 
1.3.4 Interference at the Cellular Level 
 
Understanding the means to alcohol induced fetal damage is multifaceted as the cellular 
and molecular processes that occur during normal development of the CNS are still being 
explored. Alcohol has the ability to interfere directly with the survival of brain cells; it can 
induce cell death or affect the actual cellular processes of certain CNS cells (Goodlett and 
Horn, 2001). Table 1.2 indicates the various stages of CNS development as well as the 
effects alcohol has on each stage. 
 
A number of cellular and chemical processes have been well documented as being 
disrupted by prenatal ethanol exposure; these processes include cell proliferation, 
migration and adhesion as well as neurotransmission (Guerri, 2002). Normal fetal 
development consists of three main stages of events. Firstly, cell division and proliferation 
occur followed by the second stage involving cell growth and differentiation. The second 
stage involves the specialisation of cells making them more specific in organisation and 
purpose. The third and final event involves the migration of maturing cells to their final 
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destinations within the developing embryo. Once they have reached their destination they 
will remain there and form a connection with already present surrounding cells (Michaelis 
and Michaelis, 1994). 
 
Table 1.2: The effects of alcohol on the developmental stages of the human CNS (Guerri, 
2002) 
 
 1
st
 month 
gestation 
2
nd
 trimester 
gestation 
3
rd
 trimester 
to  2
nd
 year of life 
Process of 
development 
• Neural tube 
formation 
• Neural death 
• Continuation 
of brain 
differentiation 
• Appearance 
of stem cells 
and/or radial 
glia 
• Neuronal 
proliferation 
and migration 
• Brain growing at 
its fastest rate 
• Massive neural 
cell death 
• Astrogliogenesis 
and myelin 
development 
• Functional neural 
connections 
• Differentiation of 
the cerebellum 
    
Effects of 
alcohol 
• Increased 
neural crest 
cell death 
• Severe neural 
tube defects 
such as 
hydrocephaly 
and 
craniofacial 
abnormalities 
• Abnormal 
radial glia 
• Abnormal cell 
migration 
• Neural cell 
loss 
• Prominent 
microcephaly 
• Abnormal 
astroglial 
development 
• Increase in 
apoptosis and 
necrosis 
• Alterations in 
neural 
connections 
• Alterations in the 
cerebellum 
 
Neuronal damage and loss appear to be the predominant outcomes of alcohol exposure to 
the developing CNS. An increase in programmed cell death (apoptosis) is well established 
as being one of the effects of prenatal alcohol exposure at the cellular level. The overall 
reduction in size and the partial to complete agenesis of certain regions in the brain of 
FAS individuals result from the loss of neurons through apoptosis (Olney, 2004). At the 
cellular level, cell survival, migration, adhesion and differentiation are altered. At the 
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molecular level, growth factors as well as neurotransmitters are affected by alcohol 
(Goodlett and Horn, 2001). 
  
 
1.4 NEURONAL MIGRATION 
 
During brain development, neurons are programmed to move to precise locations where 
they serve a highly specific role in the general organisational activity of the brain. New 
neurons are generated in the germinal layers of the neural tube and it is through this tube 
that they migrate to their final destinations in the various areas of the CNS. Once 
positioned, they form synaptic connections with neighbouring cells. Completion of this 
process results in a correctly developed and organised brain (Sobeih and Corfas, 2002). 
There are six distinct layers in the forebrain in which neurons settle, specific classes of 
cells reside in specific layers, this is referred to as neurogenesis. Neurogenesis takes place 
in an “inside-out” manner in that the earliest generated neurons are situated in the deepest 
layers and the later generated neurons reside in the layers closest to the surface. CNS 
migration can be separated into three distinct steps, firstly, establishment of cell identity, 
secondly directed migration and thirdly, assembly into dense neuronal layers (Hatten, 
1999). 
 
Neurons migrate in their postmitotic phase in one of two manners, radial or tangential 
migration. Radial migration involves movement of the neurons along glial fibres whereas 
cells migrating tangentially are attached to one another as opposed to glial cells and 
therefore form chains of migrating neurons (Sobeih and Corfas, 2002). Radial glial-guided 
migration is the predominant pathway in neuronal migration although recent studies have 
indicated that different neuronal populations use different modes of migration (reviewed 
in Sobeih and Corfas, 2002). 
 
Radial migration involves glial cells. Glial cells are more abundant in the CNS than 
neurons and during the process of radial migration, they form a scaffold that spans the 
entire thickness of the developing CNS, it is along these glial fibres that neurons attach 
and travel to their precise locations in the developing brain. Once the process of migration 
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is complete, glial cells change form and become star-shaped astrocytes and the migrating 
neurons are locked in position (Hatten, 1999; Dirks, 2001). 
 
1.4.1 The Effect of Alcohol on Neuronal Migration 
 
The cellular process of cell migration is a definite target of prenatal ethanol exposure. The 
brain abnormalities seen in FAS children such as hydrocephalus, partial to complete 
agenesis of the corpus callosum, microcephaly, neuroglial heterotopias and abnormal 
arrangements of neurons are all indicative of errors in migration of neuronal and glial 
elements (Clarren et al.  1978; Hirai et al.  1999). It has also been reported that irregular 
neuronal migration and a 36% reduction in the amount of glial cells from the 
somatosensory cortex have been found in animals prenatally exposed to alcohol (reviewed 
in Guerri et al.  2001). 
 
Glial cells are adversely affected by alcohol. Studies have indicated that glial cells 
exposed to alcohol transform into astrocytes prematurely. Consequently, later generated 
neurons, which would migrate and form the superficial layers of the cerebral cortex, fail to 
migrate to their proper locations and end up in abnormal positions.  This would explain 
the disorganisation of neurons found in FAS brains (Goodlett and Horn, 2001; Welch-
Carre, 2005). Table 1.2 indicates the stages of fetal development where neuronal 
migration and astroglial viability is interfered with as a result of prenatal ethanol 
exposure.  
 
 
1.5 THE GENETICS BEHIND FETAL ALCOHOL SYNDROME 
 
For a number of years researchers have been searching for genes involved in alcoholism. 
It has been reported that approximately 50 to 60% of the discrepancies in alcohol 
dependence can be attributed to genetic factors (Dick and Foroud, 2002). A likely 
assumption is that mothers of FAS children actually suffer from alcoholism. This 
therefore makes it exceptionally difficult to distinguish the genetic factors that contribute 
to alcoholism from those that cause susceptibility towards FAS. Certain environmental 
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and circumstantial factors such as availability of alcohol and poor social and economic 
status definitely increase the pervasiveness of alcoholism and consequently FAS (Viljoen 
et al.  2002). Factors like dose and timing of exposure contribute to the variation in 
diagnoses between children exposed to alcohol prenatally.  It is however likely that there 
is a strong genetic influence contributing towards susceptibility for this syndrome in 
individuals (Thomas et al.  1998). Not all women who consume alcohol during pregnancy 
produce children with symptoms of fetal alcohol damage. This therefore suggests the 
likelihood of a role for either the mother’s, child’s or both individuals’ genotypes in 
susceptibility towards, or possibly protection against FAS (Stoler et al.  2002). 
 
1.5.1 Twin Concordance Studies 
 
Studies indicating a genetic contribution towards alcohol induced birth defects have 
involved twin concordance studies. Streissguth and Dehaene (1993) carried out twin 
concordance studies with both monozygous (MZ) (identical twins, same genetic make-up) 
and dizygous (DZ) (nonidentical twins, different genetic make-up) twins of alcoholic 
mothers. Sixteen pairs of twins, of which five were MZ and eleven were DZ formed the 
study group. All twin pairs had been exposed to excessive amounts of alcohol prenatally.  
 
The study revealed that five MZ twin pairs were equally affected by the prenatal alcohol 
exposure and were diagnosed as having FAS. Of the eleven DZ pairs, only seven pairs 
showed concordance for FAS. The other four DZ pairs showed discordance. In one of 
those discordant twin pairs, one twin was clinically diagnosed as having FAS whereas the 
other twin was diagnosed with what was then referred to as “fetal alcohol effects” (FAE). 
This term is no longer used in FASD diagnosis; nowadays this child would most probably 
be classified as partial FAS, ARND or ARBD (Hoyme et al.  2005). Nevertheless, a 
diagnosis of FAE indicated that this twin did not present with all the characteristics 
necessary for a clear FAS diagnosis. In another two of the discordant DZ pairs, one twin 
had FAE and the other twin was not affected at all (Streissguth and Dehaene, 1993). 
 
Regardless of the fact that alcohol exposure within twin pairs was similar, alcohol effects 
are expressed more uniformly in MZ than DZ twins. Streissguth and Dehaene’s (1993) 
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study supports a likely role of the fetal genome as playing an important role in protecting 
against or increasing susceptibility towards alcohol induced damage. It also highlights the 
varying control the genes may have on an individual in the expression of the harmful 
effects of alcohol (Streissguth and Dehaene, 1993).  
 
Figure 1.6 is a photograph of a South African dizygotic twin pair examined by Professor 
Denis Viljoen. Their mother drank heavily during her pregnancy; one twin was born with 
all the characteristics of FAS whereas the other twin was unaffected. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Dizygotic twin sisters. The twin on the right has a clear FAS phenotype 
whereas the twin on the left was unaffected by the prenatal exposure to alcohol (photo 
courtesy of Prof. Denis Viljoen, FARR, with permission from the parents). 
 
1.5.2 Animal Models 
 
Various animals such as rodents, zebra fish, pigs and sheep have been used as models to 
explore the effects of prenatal alcohol exposure. These models have helped researchers 
understand the many means by which alcohol induces fetal damage, in relation to timing 
of exposure during the different stages of fetal development as well as dosage and pattern 
of alcohol administered (Cudd, 2005). The mouse in particular has proven to be an 
extremely good model for prenatal alcohol effect studies. The clinical presentations of 
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FAS in the mouse are remarkably similar to those seen in the human. Typical facial 
dysmorphisms, growth retardation and CNS malfunctioning are all seen in experimental 
mice models after prenatal alcohol exposure (figure 1.7) (Sulik, 2005).  
 
Figure 1.7: The similarities in the clinical presentation of FAS in the mouse versus the 
human. A child affected with FAS (a) has the same craniofacial features, including 
microcephaly, short palpebral fissures, a long upper lip and a smooth philtrum when 
compared to a mouse fetus whose mother was treated with ethanol on day 7 of her 
pregnancy (equivalent to week 3 of human gestation) (b). A normal mouse fetus of the 
same developmental stage is present for comparison (c) (taken from Sulik, 2005). 
 
Different mouse strains have also been used to explore the genetically related responses to 
alcohol induced fetal damage. One such study looked at three inbred mouse strains 
namely, C57BL/6J, DBA/2J and A/J to establish whether they vary in their susceptibilities 
to ethanol teratogenesis. These strains have long been used in alcohol research and they 
are the founding parental stocks of the most extensively genetically mapped recombinant 
inbred strains BXD and AXB/BXA. The findings revealed that both the extent and pattern 
of alcohol induced fetal damage differed by strain. Prenatal ethanol exposure increased the 
percentage of abnormalities for the C57BL/J and A/J strains (when compared to their 
relevant maltose exposed controls) but the D2 strain showed no significant difference 
when compared to its maltose exposed controls. The results also indicated that C57BL/J6 
litters had a significant increase of digit, kidney and skeletal malformations whereas A/J 
litters only appeared to have increased skeletal malformations. These results point towards 
the presence of a strong genetic component in the susceptibility to alcohol’s damaging 
effects upon fetal development (Boehm et al.  1997).  
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Another study used rats to model the responses of two genetically different strains to 
prenatal alcohol exposure. High-alcohol-sensitive (HAS) and low-alcohol-sensitive (LAS) 
rat pups were exposed to the same amount of ethanol. These two groups of rats are 
distinguished based on their sensitivity to the hypnotic effect of alcohol. After ethanol 
exposure, HAS rats were classified as being hyperactive compared to their controls. 
However, LAS rats did not differ in activity levels when compared to their controls 
(Thomas et al.  1998). 
 
These types of findings support the suggestion that the genome does have significant 
control over predisposing to or protecting against alcohol induced fetal damage. This 
therefore implies that FAS is a complex multifactorial disease, one in which both 
environmental and genetic factors play a role.                   
                  
 
1.6. COMPLEX DISEASES 
 
Genetic research has been successful in identifying genes involved in Mendelian genetic 
diseases, whereby a mutation in a single gene is responsible for a particular disease. FAS 
falls under the group of complex diseases. Complex diseases do not follow Mendelian 
inheritance; no single gene is responsible for disease pathogenesis instead, both 
environmental and genetic factors play a role, these diseases are termed “multifactorial”. 
With complex diseases there are often multiple genetic factors contributing which interact 
with each other as well as with environmental factors. Schizophrenia, diabetes mellitus, 
hypertension and the common cancers are a few examples of complex diseases in which 
genetic components as well as environmental components contribute to disease 
pathogenesis (Risch and Merikangas, 1996; Mueller and Young, 2003).   
 
For most complex diseases, the genetic component is usually the cause of an inherited 
predisposition or genetic susceptibility towards the disease. The detection of the genetic 
components of complex diseases has proved to be rather difficult as there are usually 
several genes of varying effect involved (Kwon and Goate, 2000). The search for 
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susceptibility genes in multifactorial disorders involves two different approaches, linkage 
studies and association studies (Kwon and Goate, 2000).  
 
1.6.1 Linkage Studies 
 
Linkage-based studies have been very successful in mapping single gene disorders. 
Linkage analysis makes use of affected pairs of siblings or extended families where the 
disease is prevalent. The basis of linkage studies is to analyse the degree of sharing of 
marker alleles between siblings or relatives presenting with the same trait (Schork, 1997; 
Dean, 2003). The approach involves studying the segregation of polymorphic markers, 
usually through microsatellite typing, from each chromosome in affected families until a 
marker is identified that co-segregates with the disease more often than what is expected 
to occur by chance. This then indicates that the marker and the disease are likely to be 
linked (Mueller and Young, 2003).  
 
Linkage analysis has its pitfalls when it comes to studying complex diseases. Firstly, the 
method has limited power to detect genes of modest effect and as multifactorial disorders 
have multiple genes exerting small but relevant effects, this type of study would fail to 
identify these genes. Secondly, linkage studies are not designed to evaluate many gene 
and environmental effects concurrently and thirdly, sample collection of large disease 
affected families is time consuming and costly. The most significant problem with sample 
collection for these types of studies is heterogeneity. Families from different ethnic 
backgrounds and environmental exposure can enter the study causing heterogeneity and 
thus obscuring the signal of a given gene effect (Schork, 1997). 
 
The sib-pair approach has been applied to a number of complex disorders such as cancers 
and asthma and, despite some obviously relevant loci being identified in these studies, 
most researchers have been unable to identify a locus by stringent criteria (reviewed in 
Dean, 2003). Linkage analysis is an excellent approach with high power for identifying 
rare high-risk alleles but for detection of complex disease alleles, association studies are 
far more powerful (Carlson et al.  2004). Table 1.3 lists the advantages and disadvantages 
of linkage studies. 
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Table 1.3: The advantages and disadvantages of linkage studies 
 
Study    Advantages                                    Disadvantages 
Linkage studies • High power for 
detecting rare high-risk 
alleles 
• No need to understand 
pathogenesis of the 
disease in detail  
 
• Low power for detecting 
rare risk alleles with 
moderate effects 
• Have to recruit family 
members 
 
1.6.2 Association Studies 
 
Association studies seek to test the association between gene associated deoxyribose 
nucleic acid (DNA) variants, referred to as a polymorphism, and a disease. 
Polymorphisms arise through evolution as a result of mutations, which attain significant 
frequency in populations. If the variant allele is more common in affected individuals than 
unaffected individuals then one could deduce that either there is a true association 
between the polymorphism and the disease and that the genetic variant causes 
susceptibility towards the disease or, it could be that the polymorphism is in linkage 
disequilibrium (LD) with the true susceptibility allele at a nearby locus (Schork, 1997).  
 
Association studies involve the candidate gene approach that can be assessed in one of 
two ways, the case-control method or the family-based method. Unlike linkage analysis 
where the entire genome in scanned in an unbiased manner without any presumptions 
about the role of a particular gene, the candidate gene approach allows the investigation 
into whether or not there is an association between an “educated guess” about the genetic 
basis of a disease and its pathogenesis (Kwon and Goate, 2000).  
 
For a candidate gene analysis, it is imperative that researchers have some knowledge 
about the underlying mechanisms of the disease so that they are able to choose a relevant 
gene, one that would seem logically associated with the disease (Kwon and Goate, 2000). 
Selecting a candidate gene involves knowledge of the gene and its protein product and its 
potential role in the pathways and mechanisms involved in the pathogenesis of the 
                                                                                                                                                INTRODUCTION                                       
 32 
disease. For example, in FAS one might look at the various cellular and molecular 
pathways affected by prenatal alcohol exposure and then look for genes associated with 
those particular pathways.  
 
Once the candidate gene has been selected, one needs to select which particular DNA 
variants within the gene will be assessed. There are different types of DNA variations 
namely, microsatellite repeats, insertions/deletions and single nucleotide polymorphisms 
(SNPs) (Romero et al.  2002).  
 
SNPs are the most numerous types of polymorphisms in the genome and were thought to 
occur every 500-1000 base pairs (bp) (Daly and Day, 2001). More recent research has 
reported SNP occurrence every 100-300 bp (http://www.ncbi.nlm.nih.gov/SNP) and the 
HapMap project has recorded one SNP per 279 bp (The International HapMap 
Consortium, 2005). SNPs are variations in DNA sequence where one of the four 
nucleotides is replaced with another and where the least frequent allele occurs at a 
frequency of 1% or more in the general population (Daly and Day, 2001).  
 
SNPs can be classified as coding or non-coding depending on where exactly in the 
genome they are located. Non-coding SNPs can occur in the promoter region, the introns, 
5’ and 3’ untranslated regions as well as intergenic regions. Coding SNPs occur in the 
exons of a gene. A SNP that affects an amino acid is referred to as a coding SNP or cSNP. 
Coding SNPs can either be synonymous, non-synonymous or nonsense mutations. 
Synonymous SNPs change the codon into another that codes for the same amino acid. 
Non-synonymous SNPs, also referred to as missense mutations, on the other hand change 
the codon to one that codes for a different amino acid thus potentially altering the protein 
structure and function (Romero et al.  2002). Nonsense mutations change the codon into a 
“stop codon”, UAG, UAA or UGA. This can lead to nonsense mediated RNA decay 
whereby the mRNA carrying the premature termination codon is degraded in vivo 
(Strachan and Read, 2004). 
 
Based on this knowledge, SNPs that are more likely to have functional consequences, 
such as coding SNPs, are usually the choice of SNP for candidate gene studies. It is also 
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important for researchers to look at whether or not a SNP is in linkage disequilibrium to 
other SNPs nearby, either in the same gene or a neighbouring gene. As well as looking at 
any possible association between individual SNPs and a disease, haplotype analysis, 
which involves looking at a combination of SNPs together, is also an important feature of 
candidate gene association studies (Daly and Day, 2001). 
 
1.6.2.1 Case-control Approach 
 
A case-control study involves DNA samples from affected individuals (cases) as well as 
matched controls (unaffected individuals). A case-control investigation will compare 
allelic and genotypic frequencies of a SNP in the two different groups. It is most 
important that the control subjects are matched to the cases based on ethnicity, age, sex 
and geographical positioning. Controls cannot be related to any of the case individuals. 
Mismatch between the two groups, known as population stratification, could lead to a 
false-positive association (Brookes, 1999). 
 
Case-control studies depend on the frequency of the variant allele in order to determine 
how many cases and controls are required to attain adequate statistical power to observe a 
difference in frequency between the two groups. This is not always possible as frequency 
data are not always available. A 2:1 ratio of controls to cases is a widely accepted ratio in 
case-control studies especially when the number of cases is limited due to difficulties in 
finding patients or the disease being very rare (Daly and Day, 2001).  
 
It is important to have a sufficient sample size in a case-control study. If the genetic 
contribution to a disease is small, large sample sizes will be necessary to exhibit an 
association between the polymorphism and the disease. Similarly, if the genetic 
contribution to a disease were large, a smaller sample size would be sufficient (Romero et 
al.  2002). Table 1.4 lists the advantages and disadvantages of case-control studies. 
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Table 1.4: The advantages and disadvantages of case-control studies 
 
Study Advantages Disadvantages 
Case-control 
studies 
• Simple approach  
 
• Cost effective 
 
• Easier to obtain cases 
and control samples 
compared to family- 
based studies 
 
• High power for 
detecting rare risk 
alleles with small to 
moderate effect  
• Have to have a good 
understanding of disease 
pathogenesis and the 
possible biological 
pathways involved in order 
to choose good candidate 
genes  
 
• Good understanding of 
candidate genes, their 
functions and various 
polymorphisms is required 
 
• Population stratification if 
controls are not well 
matched to cases 
 
• Large sample size required 
if genetic contribution to 
disease is small 
 
1.6.2.2 Family-based Approach 
 
The family-based approach to association studies involves the use of cases and their 
parents or unaffected siblings who act as internal controls. The use of either parents or 
unaffected siblings enables one to rule out population stratification problems (Romero et 
al.  2002). The most frequently used test in family-based studies is the transmission 
disequilibrium test (TDT). TDT compares the frequency of transmission of alleles from 
heterozygous parents to affected offspring (reviewed in Dean, 2003). It is irrelevant 
whether or not the parents are affected. It is imperative that at least one parent be 
heterozygous for the polymorphism of interest (Warren and Li, 2005). The test therefore 
classifies the transmitted alleles to affected offspring as “cases” and the nontransmitted 
alleles as “controls.” If an association were seen, the high-risk alleles would be expected 
to be amongst those transmitted as opposed to those not transmitted (Romero et al.  2002). 
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One of the drawbacks of TDT testing is the actual recruitment of parents or unaffected 
siblings. Collecting DNA samples from parents when the affected individual is still a child 
is not as problematic as collecting DNA from parents when the disease onset is late in life 
as parents might be deceased by then (Daly and Day, 2001). Deviations from the original 
TDT test include the use of single parents and unaffected siblings (Dean, 2003). The sib-
TDT is employed when one or both parents are missing (reviewed in Strachan and Read, 
2004). 
 
Both case-control and family-based approaches assume the SNP being tested does 
contribute to genetic susceptibility or that it is in LD with the true susceptibility allele. It is 
important to test SNPs at regular intervals as LD is thought to be maintained over genomic 
regions of about 5000-50000 bp of DNA (Mathew, 2001). The HapMap project has 
however clearly demonstrated that LD varies greatly across the genome and between 
populations (McVean et al.  2005; http://www.hapmap.org). 
 
1.6.3 Previous Candidate Gene Association Studies on FAS 
 
A few case-control association studies investigating the role of certain genetic 
polymorphisms in the protection against or susceptibility towards alcohol related birth 
defects have been conducted. Up until now, the focus has only been on genes involved in 
the actual alcohol metabolism pathway. Ethanol is metabolised by alcohol dehydrogenase 
(ADH) and cytochrome P450 2E1 (CYP2E1) into acetaldehyde, which is further 
metabolised by aldehyde dehydrogenase (ALDH) into acetate (McCarver et al.  1997).  
 
The ADH2 gene has been of particular interest in studies investigating the genetics behind 
alcohol related birth defects (McCarver et al.  1997). ADH2 is polymorphic and as a result 
there are different isoforms of the enzyme arising from functional polymorphisms in the 
ADH2 gene. The different variants catalyse the oxidation of ethanol at different rates 
(Viljoen et al.  2001). The ADH2*1, ADH2*2 and ADH2*3 alleles have been associated 
with FAS and ARBD in certain populations. The frequencies of these alleles differ by 
race, the ADH2*3 allele has been reported as being unique to African Americans 
(McCarver et al.  1997). 
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One of the first ARBD candidate gene investigations was performed by McCarver et al. 
(1997). The study took place in Detroit, United States of America (USA) and focussed on 
African American women and their infants. The investigators reported on the ADH2*3 
allele and found that it occurred more frequently in control mothers and infants thus 
contributing to, or being a marker for a protective effect against ARBD among African 
Americans. ADH2*3 metabolises alcohol at an increased efficiency compared to the other 
isoenzymes and so it was suggested that the protective element is secondary to the more 
effective metabolism (McCarver et al.  1997). 
 
Stoler et al. (2000) carried out a second study involving the ADH2 gene in the African 
American population in Boston, USA. These investigators also reported on the ADH2*3 
allele and contrary to the findings of McCarver et al. (1997), found that the allele was 
more prevalent in mothers who admitted to high alcohol use during pregnancy as well as 
in affected infants. This investigation concluded that the ADH2*3 allele actually increased 
the risk of fetal damage induced by prenatal alcohol exposure.  
 
In South Africa, Viljoen et al. (2001) carried out a similar genetics study in the Coloured 
population of the Western Cape Province. The investigators examined the ADH2 
polymorphisms in FAS affected children and their mothers as well as a control group. 
This study indicated that the ADH2*2 allele was significantly more common in the control 
group thus either conferring protection or acting as a marker against FAS. The ADH2*3 
allele frequency was not significantly different between the study groups. 
 
These mentioned genetic studies have been the first few to investigate the link between 
genetic polymorphisms and the effects of prenatal alcohol exposure. The ethanol 
metabolism pathway is just one of many pathways that should be explored for evidence of 
a genetic role in FAS. The best way to start analysing genes that may contribute to FAS 
susceptibility is to focus on pathways affected by alcohol such as neuronal migration and 
apoptosis. 
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1.7 THE ASTROTACTIN GENE  
 
The astrotactin (ASTN) gene was discovered in 1996 by scientists at The Rockefeller 
University and Howard Hughes Medical Institute in New York, USA. The chromosomal 
location of ASTN in the human is 1q25.2 (figure 1.8). The structure of the astrotactin 
protein (ASTN) includes a signal peptide, a recognised transmembrane domain, three 
epidermal growth factor-like (EGF-like) repeats and two fibronectin type III (FNIII) 
repeats (Fink et al.  1997). EGF repeats are found in the extracellular domains of many 
proteins and partake in intercellular signalling during neuronal development. FNIII repeats 
are known to be present in axonal glycoproteins of the immunoglobulin G (IgG) 
superfamily. The arrangement and quantity of the EGF and FNIII repeats suggests that 
ASTN is unique compared to any other cellular adhesion or signalling molecule (Zheng et 
al.  1996). 
 
 
Figure 1.8: The chromosomal location of the astrotactin gene, 1q25.2 (taken from 
http://www.genecards.org). 
 
The astrotactin family is one consisting of neuronal ligands which are neuronal adhesion 
molecules necessary for radial glial-guided neuronal movement in cortical areas of the 
developing brain (Koirala and Ko, 1998). ASTN is described as a glycoprotein and is the 
first protein shown to operate directly in neuronal migration along the glial fibres (Fink et 
al.  1997). 
 
Expression studies have indicated that ASTN is expressed by postmitotic neuronal 
precursors in the cerebrum, cerebellum, hippocampus and olfactory bulb where neuronal 
migration forms the various layers of the brain. High levels of ASTN have been 
documented in developing brains but very low levels of the protein are present in adult 
brains (Hatten, 1999). In vitro studies demonstrated that young cerebellar granule neurons 
exposed to antibodies blocking ASTN cease to migrate along the glial fibres (Zheng et al.  
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1996). Removal of ASTN reduces the rate of neuronal movement by 60% (Pearlman et al.  
1998). 
 
The ASTN gene is 303.82 kb in size and is comprised of 23 exons, its orientation is on the 
reverse strand. The ASTN protein consists of 1310 amino acids and is said to have a 
molecular weight of 145670 Da (http://www.genecards.org). 
 
A second Astrotactin gene, ASTN2, has been discovered (Sklar et al.  2002). ASTN2 is 
located on the ninth human chromosome at position 9q33.2 and appears to have a similar 
role to chromosome one’s ASTN by mediating neuronal-glial contact (Frosk et al.  2002). 
However, more detailed studies are required to gain a better understanding of the specific 
function of this gene. Due to the discovery of this second gene, the gene located on 
chromosome 1q25.2 is either referred to as ASTN or ASTN1.   
 
1.7.1 Astrotactin as a Candidate Gene for FAS 
 
Fink et al. (1997) described ASTN as “an excellent candidate gene for neuronal migration 
defects in humans.” There are a number of brain defects that arise as a result of aberrant 
neuronal migration. Failure to form normal convolutions (gyria) in the brain is caused by 
abnormal migration. Disorganisation of the laminar structure of the brain cortex as well as 
the presence of neuronal heterotopias whereby subpopulations of neurons have moved to 
inappropriate places, result from neuronal migration malfunctioning (Fink et al.  1997). It 
is a known fact that prenatal alcohol exposure disrupts the process of neuronal migration. 
Neuronal heterotopias, disorganisation of the brain cortex and an overall reduction in 
brain size are common findings of FAS brains (Clarren et al.  1978; Hirai et al.  1999) thus 
supporting the appropriateness of ASTN as a candidate gene for FAS research. 
 
Interestingly, deletions at the 1q25 position, the chromosomal location of ASTN, have 
been linked to micrencephaly (reduced brain size) in humans (Hatten, 1999). Considering 
micrencephaly is a predominant feature of FAS, ASTN appears to be a suitable candidate 
gene choice. 
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Astrotactin knockout mice have given researchers insight into the importance of this gene 
during brain development. Mice lacking the Astn gene tend to have slowed neuronal 
migration. In addition to slowed neuronal migration, a decrease in the binding process of 
the neurons to the glial scaffold is apparent and the development of the type of neurons 
known as Purkinje cells is altered. Astn null mice possess cerebella that are 10% smaller 
than wild type mice and are inherently less able to carry out tasks involving balance and 
co-ordinated movement (Adams et al.  2002). The cerebellar cortex controls movement 
and balance, thus the findings of Adams et al. (2002) support the presence of astrotactin 
protein in the cerebellum. Co-ordination and fine motor skills are poor in FAS individuals 
(Mattson et al.  2001; NIAAA, 2000) once again supporting the choice of ASTN as a 
candidate gene in FAS genetic studies.  
           
                                                                                          
1.8 THE REELIN GENE 
 
The reelin (RELN) gene is located on human chromosome seven at position 7q22 (figure 
1.9) (Pearlman et al.  1998). RELN is an extracellular matrix protein that contains a signal 
peptide followed by an N-terminal sequence and a hinge region. The hinge region is 
positioned upstream from eight RELN repeats of 350-390 amino acids (reviewed in 
Fatemi, 2005).  
 
 
Figure 1.9: The chromosomal location of the reelin gene, 7q22 (taken from 
http://www.genecards.org). 
 
RELN plays an important role in regulating radial neuronal migration in the developing 
neocortex as well as other areas of the brain such as the cerebellum and hippocampus 
(Wood, 2005). RELN protein is secreted by Cajal-Retzius neurons at the cerebral cortical 
surface. Expression of RELN peaks during the time at which neurons are generated and 
begin their migration (Lombroso, 1998).  
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Like the ASTN gene, the RELN gene is orientated on the reverse strand. The RELN protein 
is 517.73 kb in size with 24 exons and consists of 3460 amino acids. Its molecular weight 
is 3889399 Da (http://www.genecards.org; http://www.ensembl.org). The amino acid 
sequence of RELN is comparable to that of proteins secreted into the extracellular matrix 
surrounding neurons which assist neurons as they migrate (Lombroso, 1998). 
 
For many years prior to the cloning of the RELN gene, reeler mice provided researchers 
with insight into the molecular basis of CNS development (Lombroso, 1998). Reeler mice 
are autosomal recessive for a spontaneous mutation in the RELN gene (reviewed in Honda 
et al.  2003). These mice lack RELN function and as a result, fail to form the necessary 
layers in certain brain regions, especially the cerebral and cerebellar cortices. The RELN 
protein is therefore vital for correct formation of the cortical laminae (reviewed in Hatten, 
1999).  
 
As previously described, normal layering of the cerebral cortex in the developing brain 
occurs in an “inside-out” manner in that the earliest generated neurons are situated in the 
deepest layers and the later generated neurons settle in the more superficial layers (Hatten, 
1999). The reeler mutation causes the earliest generated neurons to migrate to the surface, 
the next generation of neurons then settle directly below and the final neurons form the 
deepest cortical layer (figure 1.10). The neurons therefore settle in an extremely 
disorganised, non-laminar manner (Lombroso, 1998). RELN is not produced by or 
distributed along glial cells. The initial phases of neuronal migration seem unaffected in 
reeler mice. Abnormalities lie in the termination of migration and layer formation 
(reviewed in Pearlman et al.  1998). 
 
The precise manner in which RELN acts during neuronal migration has been disputed for 
many years by a number of researchers. Several suggestions have been made and studies 
have been performed to investigate RELN’s exact mode of action. One of the most 
recognised proposed modes of action by RELN is that it acts as a neuronal migration stop 
signal by allowing neurons to detach from the glial cells once they have reached their 
proposed destination (Lombroso, 1998).  
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RELN expression is high in the developing brain but RELN levels have been observed in 
the postnatal and adult brains well after neuronal migration is completed. Postnatally high 
expression has been noted in the hippocampus, cerebellum and olfactory bulb. This 
indicates that RELN is not only a crucial protein in the embryological period but its 
presence is required for the growth and synaptic remodelling in the adult brain (reviewed 
in Zhang et al.  2002). 
 
 
 
Figure 1.10: Schematic illustration of normal versus reelin deficient cortical 
development. In the normal cortex, neurons proliferate in the ventricular zone and migrate 
along radial fibres. Early postmigratory neurons settle horizontally in the marginal zone 
(red) and subplate (pink). Reelin produced in the marginal zone (red neurons) helps 
organise postmigratory neurons into layers. Early born cortical neurons (green) are found 
in the depth of the cortex and younger cells (blue) more superficially (“inside-outside” 
gradient). In the absence of reelin signalling, cortical neurons (green) settle at an angle in 
the cortex and displace the early contingent of neurons (red and pink) all together in the 
marginal zone; the next generation (blue) cannot cross the first one and the gradient is 
directed from outside to inside (adapted from Lambert de Rouvroit and Goffinet, 2001). 
 
The pathological role of the RELN gene has been implicated in neuropsychiatric disorders 
such as autism (Bonora et al.  2003), schizophrenia, bipolar disorder, depression and 
lissencephaly (reviewed in Fatemi, 2005). 
Marginal zone 
 
Subplate 
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1.8.1 Reelin as a Candidate Gene for FAS 
 
As described, RELN plays an essential role in the correct formation of the various regions 
of the brain by assisting the neuronal migration process. Postmortem studies on FAS 
brains have often reported disorganisation of neurons and structural alterations (Goodlett 
and Horn, 2001; Welch-Carre, 2005). Mutations in the RELN gene have been connected to 
considerable learning disabilities, underdeveloped cerebella and cognitive impairment in 
both man and mouse (reviewed in Fatemi, 2005). FAS individuals suffer from learning 
problems and cognitive deficits (Welch-Carre, 2005) and MRI and postmortem studies 
have indicated overall hypoplasia of the brain, in particular reduced cerebellar volume 
(Riikonen et al.  1999).  
 
Research has also focussed on investigating a possible association between RELN 
mutations and autism (Bonora et al.  2003). This adds to the reasons for choosing RELN in 
a FAS genetics study as some of the behavioural aspects of FAS children have been 
characterised as being similar to autistic children (NIAAA, 2000). 
 
Reeler mice show neurological symptoms such as tremors, dystonia and ataxia (loss of 
muscle tonicity and co-ordination respectively) as well as abnormal neuron positioning 
throughout the cerebral cortex, cerebellum and hippocampus (reviewed in Bonora et al.  
2003). Newborn FAS infants have been described as being “tremulous” and although 
relatively rare, seizures have been reported in the neonatal period of FAS individuals 
(Clarren and Smith, 1978).   
 
The correlations between the phenotype caused by RELN mutations and the neurological 
abnormalities seen in FAS individuals support the choice of RELN as a candidate gene for 
a FAS genetic study.  
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1.9 HYPOTHESIS 
 
Certain single nucleotide polymorphisms in and around the astrotactin and reelin genes 
may have an association with, or be markers for, susceptibility towards or protection 
against fetal alcohol syndrome in the Coloured population of the Northern Cape Province 
in South Africa. 
 
 
1.10 AIMS AND OBJECTIVES 
 
The primary objective of this study was to examine genetic variation associated with the 
ASTN and RELN genes and to assess their potential role in the development of FAS in the 
Coloured population of certain regions in South Africa’s Northern Cape Province. The 
aims of the study involved examining the genotype, haplotype and allele frequencies in 
DNA samples taken from FAS children in the Upington and De Aar areas and comparing 
them to geographically and ethnically matched control samples.  
 
Specific objectives: 
i. To determine the genotype and allele frequencies of the polymorphic variants of 
the ASTN and RELN genes in the samples. 
ii. To analyse whether or not there is an association between ASTN and RELN 
polymorphisms and the predisposition to FAS. 
 
 
 
 44 
CHAPTER 2: SUBJECTS AND METHODS 
 
2.1 SUBJECT RECRUITMENT 
 
Subjects for this study resided in the towns of Upington and De Aar in the Northern Cape 
Province of South Africa (figure 2.1).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.1: A map of South Africa indicating the geographical positioning of Upington 
and De Aar (http://www.theodora.com/maps). 
 
FAS cases were identified through physical and neurological examinations performed by 
trained medical doctors, psychometrists and psychologists. Most FAS cases were young 
children of school entry age. Informed consent to take venous blood samples from FAS 
cases was obtained from the parents. Blood from 45 FAS cases, all from the Coloured 
population, was collected in total. Of the 45 cases, 24 were female and 21 male.  
 
Control individuals were recruited from the same geographical regions. The ethnic origins 
of the individual’s parents and grandparents were recorded. However, no information was 
obtained on whether control individuals were or were not exposed to alcohol in utero. 
Although it would be ideal to have controls that were exposed to alcohol prenatally and 
did not develop FAS, it is exceptionally difficult and ethically challenging to achieve this. 
Only individuals with at least three Coloured grandparents were included. Control 
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individuals had to be 18 years old or older for informed consent purposes. In total 112 
control subjects, 57 females and 55 males were collected for this study. These individuals 
did not undergo any physical or neurological examinations. They were considered to be a 
random sample of the study population. From each case and control individual, 10 ml of 
blood was drawn into EDTA (anticoagulant) tubes. Case and control samples were 
numbered consecutively. “NPF” was used as the code for cases and “NPC” was used for 
controls. The blood was stored in a cooler bag and sent to the Molecular Genetics 
Laboratory at the National Health Laboratory Service (NHLS) in Braamfontein, 
Johannesburg.  
 
Previous ethics approval was granted for blood extraction by the Research Ethics 
Committee of the University of the Witwatersrand, reference numbers: M02-10-41 and 
M03-10-20 (Appendix A). 
 
 
2.2 DNA EXTRACTION 
 
Once the blood samples had reached the laboratory they were frozen at –200C. After 
defrosting at room temperature, DNA was extracted using the Flexigene DNA extraction 
kit manufactured by Qiagen. Appendix C describes the protocol. 
 
 
2.3 DNA QUANTIFICATION AND STORAGE 
 
Once extracted and resuspended in the provided buffer, the concentration of each DNA 
sample was quantified using the Nanodrop ND-1000 spectrophotometer. DNA 
concentration is determined by measuring the absorbance of ultraviolet (UV) light at a 
wavelength of 260 nm. As well as the concentration being determined by the Nanodrop, 
the purity of the DNA was also measured at a wavelength of 280 nm. The 260/280 ratio is 
indicative of the DNA purity. A ratio of 1.8 indicates pure DNA; a result of less than one 
would suggest protein contamination.  Working stocks of each sample were made at a 
concentration of 100 ng/µl using double distilled water (ddH2O). Working stocks were 
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kept at 40C. For each case and control sample, 200 µl of undiluted DNA was stored at      
–200C and the remainder of the extracted DNA was kept at –700C. The quality of the 
extracted DNA was of a very high standard which made genotyping of all 45 cases and 
112 controls easily achievable. 
 
 
2.4 CANDIDATE GENE CHOICE 
 
Astrotactin and reelin were selected for this particular FAS genetics study. Text mining 
was the major procedure employed to select suitable candidate genes. Numerous journal 
articles and literature reviews covering topics such as FAS, the developing CNS, neuronal 
migration and the genes involved in these processes were read. Due to their crucial role in 
the process of neuronal migration the ASTN and RELN genes were decided upon for 
investigation. The Ensembl ID for the ASTN gene is ENSG00000152092, transcript 
ENST00000361833. The RELN gene ID on Ensembl is ENSG000001899056, transcript 
ENST00000339713. Ethics approval (protocol M040611) was obtained from the 
University of the Witwatersrand’s Research Ethics Committee for the investigation of 
ASTN and RELN SNPs in the Northern Cape DNA samples (Appendix A). 
 
 
2.5 SELECTION OF SINGLE NUCLEOTIDE POLYMORPHISMS  
 
The Ensembl database (http://www.ensembl.org) was accessed to retrieve a list of all 
reported SNPs within each of the candidate genes. The database listed whether the SNPs 
were present in exons, introns or untranslated regions (UTRs). The functionality, 
chromosomal and amino acid (aa) positioning was also specified. In addition to that, the 
database provided information on whether or not a SNP had been verified by frequency 
studies or cluster analysis or whether it was merely suspected.  
 
In cases where SNPs had been verified, the allele and genotype frequencies across several 
populations were stated. In order to locate the respective SNPs within the genomic 
sequence of each gene, the genomic sequences for ASTN and RELN were downloaded 
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from the University of Santa Cruz (UCSC) Genome Bioinformatics website 
(http://genome.ucsc.edu). 
 
2.5.1 Astrotactin SNPs 
 
Table 2.1 lists the four ASTN SNPs chosen for investigation. (See Appendix B, figure B2 
for a schematic diagram of all SNPs present in ASTN).  The three non-synonymous SNPs 
were chosen due to their potential for functional impact; a change in amino acid can cause 
serious alterations to the structure of the protein. An additional SNP, the 3’ UTR SNP was 
selected, as frequency data was available for comparison. Figure 2.2 illustrates the chosen 
SNPs on chromosome one indicating their base pair positioning. “Status” represents 
whether or not the SNP has been proven in certain populations or if it is just suspected 
 
Table 2.1: SNPs in the ASTN gene chosen for investigation 
Ensembl ID Alleles 
(forward 
strand) 
SNP type Chromosomal 
positioning 
SNP 
Status* 
aa 
change 
aa 
site 
rs6413830 G → A 3 prime UTR 173564209 Verified - - 
rs12118933 G → C Non-synonymous, 
coding 
173565154 Suspected R/G 1285 
rs2228956 T → C Non-synonymous, 
coding 
173595524 Verified H/R 939 
rs11587640 G → T Non-synonymous, 
coding 
173733291 Suspected L/M 282 
 
* The term “SNP status” refers to the extent to which the SNP has been investigated. If 
“verified”, it means that it has been confirmed in one or more populations and genotype 
frequencies are available. If it is “suspected” to occur it has not yet been validated through 
research in human populations. 
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         I---------------------------137676 bp---------------------------I--------30370 bp---------I-945 bp-I 
 
Figure 2.2: A schematic representation of the selected ASTN SNPs orientated on the 
reverse strand. The base pair position of each SNP on chromosome one is indicated as 
well as the base pair distance between them.  
 
2.5.2 Reelin SNPs 
 
Table 2.2 indicates the four RELN SNPs selected for the study (see Appendix B, figure B3 
for a schematic diagram of all SNPs present in RELN). All four SNPs are non-
synonymous coding SNPs that cause amino acid changes. Figure 2.3 illustrates the base 
pair positioning on chromosome seven of the selected SNPs. 
 
Table 2.2: SNPs in the RELN gene chosen for investigation 
Ensembl 
ID 
Alleles  
(reverse 
strand) 
SNP type Chromosomal 
positioning 
SNP 
Status* 
aa 
change 
aa site  
rs607755 T → C Non-synonymous, 
coding 
102983905 
 
Verified L/S 199 
rs3025963 A → T Non-synonymous, 
coding 
102845204 Suspected E/V 973 
rs3025966 T  → G Non-synonymous, 
coding 
102864505 Suspected A/C 852 
rs362691 C → G Non-synonymous, 
coding 
102845112 
 
Verified L/V 1004 
 
* The term “SNP status” refers to the extent to which the SNP has been investigated. If 
“verified”, it means that it has been confirmed in one or more populations and genotype 
frequencies are available. If it is “suspected” to occur it has not yet been validated through 
research in human populations. 
rs11587640 
173733291 bp 
Exon 3 
rs2228956 
173595524 bp 
Exon 17 
  rs12118933 
  173565154 bp 
  Exon 23 
 rs6413830 
 173564209 bp 
 3’ UTR 
   5’ 3’ 
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Figure 2.3: A schematic representation of the chosen RELN SNPs orientated on the 
reverse strand. The base pair position of each SNP on chromosome seven is indicated as 
well as the distance between them.  
 
 
2.6 PRIMER DESIGN 
 
In order to amplify the DNA region flanking each SNP by means of the polymerase chain 
reaction (PCR), oligonucleotide primers that are complementary to the region need to be 
designed. Primer design was performed both manually, by viewing the genomic sequence 
on either side of each SNP, and with the assistance of a bioinformatical program, Primer3 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). 
 
The number of primers designed per SNP was dependent upon the proposed mode of 
detection of the alleles. All but one of the eight SNPs investigated were restriction 
fragment length polymorphisms (RFLPs) (described below). For RFLPs only two primers 
are required, a forward and a reverse primer. When a SNP cannot be detected by an RFLP 
method another mode of detection is required. This study chose the amplification 
refractory mutation system (ARMS) whereby three primers are required for allele 
5’  3’  
rs607755 
102983905 bp 
Exon 5 
rs3025966 
102864505 bp 
Exon 19 
rs3025963 
102845204 bp 
AND 
rs362691 
102845112 bp 
Both Exon 21 
19301 bp between 
rs3025966 & 
rs3025963 
92 bp 
between 
rs3025963 
& rs362691 
   I----------------------------------119400 bp-------------------------------I-----------I
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detection per sample and an additional set off primers is required to serve as an internal 
PCR control. In total, ARMS requires five primers (Ye et al. 2001; 
http://www.ich.ucl.ac.uk/cmgs/arms99.htm).  
 
When designing primers several factors including the GC content and consequently 
melting temperature of the primers were taken into consideration. Once primers had been 
designed they were verified against the human genome using Ensembl’s BLAST function. 
This function allowed one to visualise at what locations in the human genome the primers 
bound to. Ideally, primers should only amplify one product, the desired DNA sequence 
containing the SNP. In order to achieve this, adding some base pairs onto or subtracting a 
few from one or both primers increases specificity.  
 
Once a pair of primers had been selected, they were entered into a program called UCSC 
In-Silico PCR (http://www.genome.ucsc.edu) where a virtual PCR reaction would take 
place. The program reported the melting temperature of each primer and the size of the 
PCR product yielded by each reaction. This program confirmed that only one product was 
expected per reaction and also gave an indication as to what range the annealing 
temperature should fall into.  
 
 
2.7 TECHNIQUES EMPLOYED 
 
2.7.1 Polymerase Chain Reaction 
 
PCR is a process that allows selective exponential amplification of a specific DNA 
sequence. It is a rapid and relatively simple procedure that is highly sensitive. Only a very 
small amount of starting DNA is required for a PCR reaction. Each PCR reaction requires 
a forward and reverse oligonucleotide primer, a thermostable DNA polymerase (isolated 
from the heat-stable bacterium Thermophilus aquaticus and therefore referred to as Taq 
polymerase), deoxynucleotide triphosphates (dNTPs) and double stranded DNA. 
Magnesium chloride (MgCl2) and a buffer are also added to the reaction to supply optimal 
conditions for the polymerase. Each PCR reaction consists of several cycles of 
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temperature fluctuations that result in DNA denaturation, primer annealing, primer 
extension and hence DNA synthesis (Mueller and Young, 2003). 
 
For each of the ASTN and RELN RFLPs basic PCR was used to amplify the regions 
flanking the SNPs. For RELN’s rs362691 an ARMS PCR system was designed to detect 
the two alleles. Appendix C lists the ingredients used for the PCR reactions used in this 
study.  
 
2.7.2 Restriction Fragment Length Polymorphisms  
 
RFLPs are SNPs whose alternate alleles either introduce or remove a cleavage site for a 
specific restriction enzyme. RFLPs can be detected after PCR through the digestion of the 
PCR product with the appropriate restriction enzyme. RFLPs are effective and usually 
simple and detection of genotypes is relatively rapid and easily distinguishable. 
Temperatures at which digestion takes place and the amount of time required for 
appropriate digestion varies amongst the different enzymes. Digestion products are 
viewed by gel electrophoresis. The web-based program, known as NEBcutter 
(http://tools.neb.com/NEBcutter2/), by New England Biolabs, was used to detect which 
restriction enzyme sites were present around each SNP. Once an enzyme had been 
selected, NEBCutter performed a virtual digest and listed the digestion product sizes.  
 
2.7.3 Amplification Refractory Mutation System  
 
The principle behind an amplification refractory mutation system (ARMS) is the 
distinction of the different alleles of a SNP through the use of primers that differ by a 
single nucleotide at the 3’ terminus. An ARMS primer is designed so that it can 
differentiate between templates that vary at a single nucleotide residue. A typical ARMS 
procedure consists of two separate reactions and utilises three primers. One reaction 
involves a primer whose 3’ terminal residue is complementary to the “wild type” allele 
and the other reaction involves a primer whose nucleotide at the 3’ end is complementary 
to the “mutant” allele. A third primer is designed which is constant and complementary to 
the DNA template in both reactions. Two reactions are therefore carried out per DNA 
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sample.  If a sample is homozygous for the “wild type” or “mutant allele,” amplification 
will occur in one reaction only. If however, a sample is heterozygous in that it has both the 
“wild type” and “mutant allele,” amplification will take place in both reactions 
(http://www.ich.ucl.ac.uk/cmgs/arms99.htm).  Results of each reaction are detected by gel 
electrophoresis. 
 
ARMS primers are usually 30 bases in length and the GC content should be about 50%. It 
is important that the nucleotide mismatch is always at the 3’ terminal end of a primer. 
When referring to the alleles involved in a SNP (the inherent mismatch), there are two 
main types of mismatches, strong and weak. A strong mismatch is a SNP involving a 
G→A or a C→T transition and a weak mismatch is one that involves a C→A or a G→T 
transversion. In order to make priming more specific in an ARMS reaction, it has been 
suggested that a second mismatch (an artificial mismatch) be introduced into the allele 
specific primers. This second mismatch usually occurs one or two bases from the 3’ end. 
When introducing a second mismatch it is important to take into consideration what type 
of mismatch, strong or weak, the SNP is classified as. An initial strong mismatch will 
require a weak second mismatch whereas a weak inherent mismatch will call for a strong 
second artificial mismatch (Ye et al.  2001). 
 
2.7.4 Agarose Gel Electrophoresis 
 
Electrophoresis is a process by which charged molecules migrate through an electric field. 
The rate of migration is dependent upon the size of the molecules and their electric 
charge. Gel electrophoresis involves loading the DNA mixed with a loading buffer which 
weights the DNA and prevents it from floating out of the wells, into prepared wells of a 
gel. A gel consists of a network of fibrils and the researcher can control the pore size 
during gel preparation. The DNA molecules migrate through the pores of the gel under the 
influence of an electric current, the negatively charged molecules move from the negative 
to the positive electrode. Larger fragments will migrate at a slower rate than smaller 
fragments thus separating fragments by size. The loading buffer (which includes a 
tracking dye) is coloured and allows one to visually track the movement of dye through 
the gel. Ethidium bromide, which is an intercalating agent, is added to gel mixtures. 
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Ethidium bromide binds to the DNA and fluoresces under ultraviolet light allowing one to 
visualise the DNA fragments (Madigan et al.  2000). A DNA ladder with known standard 
sizes is always loaded in one of the wells of a gel. This ladder is used to estimate the size 
the DNA fragments. 
 
Agarose gels are prepared with powdered agarose and 1 X Tris Borate EDTA (TBE). The 
mixture is heated until the agarose has completely dissolved, and once slightly cool it is 
poured into a horizontal tray where combs are inserted to create wells (see Appendix D). 
The pore size of gels can vary depending on agarose concentration. High percentage gels 
have smaller pores than low percentage gels. The DNA molecules suspended in a gel 
migrate through the pores at rates dependent upon their molecular weight. Small 
molecules will migrate faster than large ones. High percentage gels are therefore useful 
when separating very small fragments as the decreased pore size slows the migration of 
the small DNA molecules down thus separating them effectively. 
 
Agarose gel electrophoresis was used to separate and estimate the size of the DNA 
fragments generated by PCR and restriction enzyme digestion. Five microlitres of each 
PCR product was mixed with Ficoll dye and then run on a 3% agarose gel and 15 µl of 
each digestion reaction was mixed with Ficoll dye and run on a 4% agarose gel. All gels 
were run at a voltage of 4 V/cm. Depending on what sizes were expected, the 1Kb Plus 
(from Invitrogen) or HyperLadder V (from Bioline) DNA markers were used as size 
standards. Appendix C lists the fragment sizes of each DNA marker and Appendix D 
indicates how the 1Kb Plus DNA ladder and Ficoll dye were prepared. HyperLadderV 
was manufactured in a ready-for-use state. 
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2.7.5 DNA Sequencing 
 
DNA sequencing was utilised to confirm the RFLP and ARMS results. The ABI 3130 
Genetic Analyzer (capillary sequencer) by Applied Biosystems that applies the Sanger 
dideoxy-chain termination method was utilised.  
 
Prior to cycle sequencing the PCR product was purified. This purification step was 
performed using the Nucleospin Extract II kit by Macherey-Nagel. The cycle sequencing 
reaction is similar to a PCR reaction in that it requires a thermostable DNA polymerase 
and cycles of fluctuating temperatures resulting in DNA denaturation, primer annealing 
and DNA synthesis. However, there are some significant differences between cycle 
sequencing and conventional PCR. Firstly, cycle sequencing requires only one primer, 
either the forward or reverse as opposed to both. This results in linear amplification of 
DNA versus PCR’s exponential amplification. Secondly, dideoxynucleotides (ddNTPs) 
labelled with fluorophores are added to serve as chain terminators, these differ from 
dNTPs in that they lack a 3’-hydroxyl group. The incorporation of a ddNTP into a 
growing DNA chain causes termination of chain synthesis, as a 5’ to 3’ phosphodiester 
bond cannot be formed without a 3’ hydroxyl. The reaction involving the incorporation of 
ddNTPs will therefore produce molecules that vary in length. Each of the four ddNTPs is 
labelled with a different fluorophore (Wilson and Walker, 1995; Strachan and Read, 
2004).  
 
Before a cycle sequencing product can be size fractionated it was purified, vacuum dried 
and denatured. Once these three processes have been completed the cycle sequencing 
product is ready to be loaded into the automated ABI 3130 Genetic Analyzer. Purification 
was carried out using the Qiagen Di-ex spin columns.  
 
The 3130 instrument requires samples to be loaded in 96-well plates. Minute volumes of 
each DNA sample are sucked up into individual capillary tubes filled with gel. 
Electrophoresis occurs and the DNA fragments migrate through the tubes from the 
cathode to the anode. During electrophoresis the different sized DNA products pass by an 
optical sensor that detects which ddNTP terminated them by identifying the different 
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fluorescence signals emitted. The output from the optical sensor is recorded onto a 
computer and an intensity profile is created (Wilson and Walker, 1995). An 
electropherogram is the physical output of sequence data that illustrates the different base 
specific intensity profiles.  
 
For each SNP, two samples of each genotype found were sequenced in order to confirm 
the RFLP and ARMS results. For every sample, a forward sequence reaction as well as a 
reverse sequence reaction was done. Occasionally, only one of the reactions worked. In 
the results section both the forward and reverse sequences are presented if both reactions 
were successful otherwise the results of one of the reactions are shown. See Appendix C 
for the cycle sequencing protocol and purification steps. 
 
2.7.6 Standard Laboratory Procedures  
 
For each RFLP the same course of action was employed in order to detect the various 
genotypes. This included:  
i. PCR reaction to generate desired PCR product 
ii. Agarose gel electrophoresis confirming the correct size of the PCR product 
iii. Specific restriction enzyme digestion 
iv. Agarose gel electrophoresis to detect the digestion products (different genotypes) 
v. DNA sequencing to confirm genotypes generated by enzyme digestion 
 
ARMS detection involved the following procedures: 
i. Two PCR reactions per sample (differing in the forward primer used) 
ii. Agarose gel electrophoresis to detect whether or not a PCR product was produced 
in each reaction 
iii. New PCR reaction using an upstream primer and the common reverse primer (no 
control primers) to generate a single PCR product encompassing the SNP site for 
sequencing purposes 
iv.  DNA sequencing to confirm the different genotypes obtained 
 
 
                                                                                                        SUBJECTS AND METHODS 
 56 
2.8 ANALYSIS OF ASTROTACTIN AND REELIN SNPs 
 
The genotypes obtained for the ASTN and RELN SNPs in every case and control subject 
are listed in table B1 in Appendix B. 
 
2.8.1 Astrotactin SNPs 
 
The first step of analysis for each SNP involved performing a temperature gradient to 
detect the optimal primer annealing temperature. All ASTN primers were synthesised by 
Inqaba Biotech and separate temperature gradients for each primer pair were carried out 
on the 2720 thermal cycler (Applied Biosystems). The same temperature gradient was 
used on all four primer pairs; the gradient was centred at 570C and fluctuated by 70C in 
either direction. Control DNA was used for each temperature gradient. Once PCR 
products from the temperature gradients were run on 3% agarose gels at 4 V/cm, the 
brightest and most defined band of the correct size determined the optimal annealing 
temperature.  
 
Interestingly, all four ASTN PCR reactions performed optimally at an annealing 
temperature of 63.40C. All four PCR reactions were carried out on the GeneAmp thermal 
cycler (Eppendorf). The following PCR protocol was therefore used for all four reactions: 
 
Initial denaturation  950C  7 mins 
Denaturation  940C  30 secs 
Annealing   63.40C  30 secs 
Extension   720C  40 secs 
Final extension  720C  5 mins 
Hold   150C  ∞ 
 
 
 
 
 
30 cycles 
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2.8.1.1 rs6413830 
 
ASTN’s rs6413830 involves a G→A transition in the 3’ UTR. The positioning of the SNP 
on the forward strand and the areas upon which the primers anneal are indicated below in 
green:  
 
 5’CCAAGCCTTACCTGTCCAAGGTAAGAGGTGTGGGGGTTAAAGATAATCCAGGCACAT 
 GGATATATATTGGTAGGCTGGAGAAGTCTATCCAAAGGAAGCATGGTTTTTTTAAAAAA 
 CAATAAACTCCAAGTCTCCTCTTGAATGTGGACTGCTAACTAGTCTCCCAGGTAGACTT 
 TTCTGAAGGTGCAGTTGACAGATGGCAT 3’ 
 
Forward Primer: 5’ CCAAGCCTTACCTGTCCAAG 3’ 
Reverse Primer: 5’ATGCCATCTGTCAACTGCACCTTCAGAAAA 3’ 
 
A PCR reaction incorporating the above primers yielded a PCR product of 203 bp. The 
size of the PCR product was determined on a 3% agarose gel run at 4 V/cm. Prior to 
loading of the sample, 5 µl of Ficoll dye was added to 5 µl of PCR product. HyperLadder 
V was loaded as a DNA marker alongside the PCR products. Once the electrophoresis run 
was completed, the gel was viewed using the gel documentation system (Syngene).  
 
This particular SNP is an RFLP, the presence of the “A” allele creates a recognition site, 
“AGCT” for the enzyme AluI. Digestion reactions totalled 30 µl. Each reaction contained 
20 µl of PCR product, 0.5 µl (5 units) AluI (manufactured by Fermentas), 3 µl 10x 
TangoTM Buffer and 6.5 µl ddH20. The digestion reaction took place at 37
0C for 2.5 hours 
and digestion products were run against HyperLadder V on a 4% agarose gel and viewed 
using the gel documentation system.  
 
This particular enzyme does not have star activity and so over digestion was not a 
concern. It did however require thermal inactivation at 650C for 20 minutes. The expected 
results following AluI digestion are illustrated in figure 2.4.  
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                _________ 203 bp                _________ 203 bp 
 
 
                _________ 129 bp            _________ 129 bp 
 
 
                _________ 74 bp            _________ 74 bp 
      
               Homozygous G/G              Homozygous A/A                 Heterozygous G/A 
             
Figure 2.4: The three possible genotypes at rs6413830 following AluI digestion.   
 
2.8.1.2 rs12118933 
 
ASTN’s rs12118933 involves a G→C transition within exon 23 that causes an amino acid 
change. The positioning of the SNP on the forward strand and the areas upon which the 
primers anneal are indicated below in blue:  
 
  
Forward Primer: 5’ TGCGGCAGGCCTAACAACT 3’ 
Reverse Primer: 5’ GCGGCGCAGCTCACTCAAG 3’ 
 
The product formed from a PCR reaction involving the above primers was 593 bp in size. 
PCR products were viewed on a 3% agarose gel using the 1 Kb Plus DNA marker. The 
presence of the “G” allele produces a “CCGG” recognition site for the enzyme MspI.  
 
5’TGCGGCAGGCCTAACAACTTTCTGGCCTCACCTCTGCTCCCAGTTGCAATGGATTTA
GGAACTGAGTGAGCACAGGGTGCCTACTTAATAGACTTTTCATGGGGAGCACGGCAGAG
CTCTTGAGCATTTTGGTAAACTTCTCAGGGAAAAAAAAATGAATGGAACAAATTAATGG
CAAAGCAAACCCCAAAGTAATCCTCTAAAGAAATATGGCACTGCATGAAGCCACTGGCT
GGCAGATTTCCCAATCATGCAGATGGAGAACATCATACTGAAGAAGTTCTGCAGGGAGC
AAGGATCACTTTCTCCCTGGTTTCGATGTTGCTGTGGAGGTTTTCATGTTCCATTAAAA
AATATTAAAAATCCACAGACCAACCCAGATGGATCCCTCCTCTTTCCTACTTCATTCTG
GCAGCAGCTCCCTGGCCTTATGGTGCTAGATCTCTTTGCTGTCCCCATAGTCGTTGTAG
GGGATACTCAGGGTCTGCTCCTCACACGTCTTCCTGAGGTCCCGGCTGAGCTCCGCCCA
GTCAAGTCCGTAGGGTTTGATCTCGCTGTAGCGGCACCCCAGGTACTTGAGTGAGCTGC
GCCGC 3’ 
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Once it was confirmed that the correct PCR product had been amplified, digestion with 
MspI followed. Each digestion reaction contained 10 µl of PCR product, 0.5 µl (5 units) 
MspI (Amersham Biosciences), 3 µl 10x Buffer T, 3 µl bovine serum albumin (BSA) and 
3.5 µl ddH20. The optimal temperature for this digestion reaction was 37
0C and the 
incubation period was 3-5 hours. Digestion products were confirmed on a 4% agarose gel 
and their sizes were estimated with the use of the 1Kb Plus DNA ladder. The three 
possible genotypes generated from MspI digestion are illustrated in figure 2.5. 
 
 
Figure 2.5: The expected genotype results at rs12118933 following MspI digestion.   
 
2.8.1.3 rs2228956 
 
ASTN’s rs2228956 is present in exon 17 of the ASTN gene and involves a T→C base 
transition, which results in an amino acid change. Depicted below is the SNP position and 
the DNA sequences complementary to the designed primers on the forward strand of the 
ASTN gene: 
 
5’CCGGCTCAGCAGGGGTGTCAGGGCTGGATGTCACATGACACAGGGGGCAGGACGAGG
GGCATCGTCCCTTGCTGTGGCACTCCATGCGGACTCCAGCCGCCATGTGCTTGGTGCCG
GAGTCTGACAAGCTGGTGATGTATTCTGGGAATGTCAGCACCTTGGGGTCTCTTTCCCG
CTCCTCAGACTCATCTGATGGGGAGTTGCCTGCAGACACAAAATGGAAAGAAACAGTGA
AGGAGTCAAAAAAGTAAGGACTATCATGACCTCGTGGCCCCTGAGTGCTGGGGTCCAAT
CTTTGGGATCAGAAACAGCCACTGAAGGGGTAAGAATGTGATTCTGCCATCCCACTTAA
TTTGGGGCACCCAACCTCCCAGCGACACA 3’ 
            
            _________ 593bp                ________ 593 bp 
              _________ 512 bp                   ________ 512 bp 
 
 
 
             _________ 81 bp             ________ 81bp 
 
          Homozygous C/C         Homozygous G/G                   Heterozygous G/C 
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Forward primer: 5’ CCGGCTCAGCAGGGGTGTC 3’ 
 
Reverse primer: 5’ TGTGTCGCTGGGAGGTTGG 3’ 
 
A product of 381 bp was amplified using these primers. As before, PCR products were 
checked on a 3% agarose gel. HyperLadder V was used as the DNA marker.  Rs2228956 
is also an RFLP, when the “C” allele is present HhaI recognises the “GCGC” sequence 
and cleaves it.  
 
Digestion of the 381 bp PCR product involved 20 µl of PCR product, 0.5 µl (5 units) of 
HhaI (Fermentas), 3 µl 10x TangoTM Buffer and 6.5 µl ddH20. The HhaI reaction was 
incubated at 370C for 3 hours after which the enzyme was inactivated at 800C for            
20 minutes. Digestion products were run on a 4% agarose gel at 4 V/cm against 
HyperLadder V. The expected results for the HhaI digestion are indicated below in figure 
2.6. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6: The expected band pattern on a gel of the genotypes at rs2228956 following 
HhaI digestion. 
 
 
 
 
            
_________ 381 bp                                                           _________ 381 bp 
   
                                                         ________275 bp      _________ 275bp 
  
 
                                                        ________106 bp                   _________ 106 bp 
 
           Homozygous T/T             Homozygous C/C      Heterozygous T/C 
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2.8.1.4 rs11587640 
 
ASTN’s rs11587640 is a non-synonymous coding SNP located in exon 3. The allele 
transition involved is G→T. The position of the SNP on the forward strand and the areas 
of primer binding are depicted in purple below: 
 
       
  
Forward Primer: 5’ CTGGTGTGAGGTCCATCCCCG 3’ 
Reverse Primer: 5’ AGCATCCGGGAGACACCTAT 3’ 
 
A PCR product of 172 bp was synthesised from the above primers. All PCR products 
were viewed as described previously. This SNP is an RFLP and can therefore be detected 
by enzymatic digestion. The “G” allele creates a recognition site, “CCTGCAGG” for SbfI. 
A digestion reaction involved, 20 µl of PCR product, 0.5 µl (5 units) SbfI, 3 µl 10x 
NEBuffer 4 and 6.5 µl ddH20. New England Biolabs manufactured SbfI and NEBuffer 4. 
The reaction was incubated at 370C for 3 to 16 hours (see results section) after which the 
enzyme was inactivated for 20 minutes at 650C. The predicted results after SbfI digestion 
are specified in figure 2.7 below. 
 
Figure 2.7: The three predicted genotypes at rs11587640 generated by SbfI digestion. 
                                                     _________ 172 bp                _________ 172 bp 
   
             ________130 bp                   _________ 130 bp 
  
 
            ________ 42 bp                                                               _________ 42 bp 
 
      Homozygous G/G               Homozygous T/T    Heterozygous G/T 
 
5’CTGGTGTGAGGTCCATCCCCGACTTTTCATTGCAGCCCTGCAGGGAGTCGAGGGTGC 
GCGTGACCTGGCTGGCAAAGTCCTCCCCTCCGTTCATGCACTCCCTCTGCAGATGGTGG 
CGCAGATCAGTGATGTCATACTCATAGCCGTCCAGGATAGGTGTCTCCCGGATGCT 3’ 
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2.8.2 Reelin SNPs 
 
Unlike the ASTN SNPs, the PCR protocols for the four RELN SNPs all differed from each 
other. The individual PCR programmes are listed under each separate heading below. 
Inqaba Biotech manufactured the RELN primers. All PCR reactions were optimised with a 
temperature gradient using the Applied Biosystems 2720 thermal cycler. Three of the four 
RELN SNPs were RFLPs and were therefore detected through enzyme digestion. For the 
three RFLPs, 5 µl of each PCR product was loaded with 5 µl of Ficoll dye onto 3% 
agarose gels run at 4 V/cm.  Digestion products were run on 4% agarose gels at the same 
voltage. I Kb Plus DNA marker or HyperLadder V were used depending on the size of the 
DNA fragments.  All gels were viewed using the Syngene gel documentation system. The 
ARMS system only required a 3% agarose gel upon which the PCR products were run. 
 
2.8.2.1 rs607755 
 
The rs607755 SNP entails a non-synonymous T→C alteration. The SNP is highlighted 
below and the positioning of the primer pair on the reverse strand is illustrated in green:  
 
 5’GTCCCGAATAGCCTCTCCTTGTAGGTTGGTGCTGATTTTGGCCTTCCTGCCTTG 
 CCTGCCTAGTGATAGCTTCATAGATTTCCTTTTGGGGTCTTTGGTTTTCCCAACTT 
 CTAGGTGTTTAAACCGCAGAGCTTTTTACCCTTGTCCCTTAGTAGTTTGAGGGACA 
 AAGCAAATATAATCAACTGCTCATTTAAAATTTAGTTTTAGGATACATTATTCTTC 
 ATAAATACAGCATGTTGGCACTTGTGTTTAGCTAAATGTACTGTTGTAGTATATTT 
 CTTTCCTAAATACTTCCTTTTTCTTTTAGCTGAAATACATAGTGACAGCATTATCC 
 TGAGAGATGACTTTGACTCCTACCACCAACTGCAATTAAATCCAAATATATGGTAA 
 GTTACAGGAACATTCCTCACTTTGGTTTGCTTAATGTAACAAATGATGCTGACTGC 
 TCCTTTAAGGAGCAGTTACTTAAAATTAAGTTGATCTTTAGTGCTAAGCTATCAGT 
 GAGACTTGTTAAGCTATGGAACTGGGC 3’ 
 
Forward Primer: 5’ GTCCCGAATAGCCTCTCCTT  3’ 
Reverse Primer:  5’ GCCCAGTTCCATAGCTTAACA 3’ 
 
A temperature gradient was performed to find the optimum annealing temperature for the 
PCR reaction. The gradient was centred at 580C and fluctuated by 50C in either direction. 
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An optimum annealing temperature of 62.60C was obtained and the PCR reaction yielded 
a 529 bp product. The PCR parameters were set at: 
 
Initial denaturation  950C  7 mins 
Denaturation  940C  30 secs 
Annealing   62.60C  30 secs 
Extension   720C  40 secs 
Final extension  720C  5 mins 
Hold   150C  ∞ 
 
The change of allele from a T→C results in a recognition sequence, “CAGCTG” for    
PvuII. This enzyme was used to digest the 529 bp PCR product at 370C for 2 hours. Each 
digestion reaction included 20 µl of PCR product, 0.5 µl (5 units) PvuII, 3 µl Buffer G and 
6.5 µl ddH20. The enzyme and buffer were both manufactured by Fermentas. The 
expected DNA fragments resulting from digestion with PvuII, are illustrated in figure 2.8. 
 
Figure 2.8: The expected fragments after PvuII digestion of the PCR products containing 
rs607755. 
 
 
 
30 cycles 
            
   _________ 529 bp              _________ 529 bp 
 
 
 
                     
                    _________ 307 bp               _________ 307 bp 
 
 
 
        _________ 222 bp               _________ 222 bp                
 
     Homozygous T/T                    Homozygous C/C     Heterozygous T/C 
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2.8.2.2 rs3025963 
 
RELN’s rs3025963 consists of an A→T transition. This SNP is also an RFLP, when the 
“A” allele is present a recognition site, “GAATGCN” for the enzyme Mva12691 is 
produced. Mva12691 is the Fermentas isoschizomer for BsmI. The areas of primer binding 
and the position of the SNP on the reverse strand can be seen in pink below: 
 
Forward Primer: 5’ TGTATGTGCGAGTATTGGGAAA 3’ 
Reverse Primer: 5’ TGACAACTTGGCATACTTGGA 3’ 
 
A temperature gradient was performed on the above primers; the middle temperature was 
set at 59.50C and fluctuated by 50C in both directions. An optimum annealing temperature 
of 63.10C was obtained.  
 
The PCR parameters for the amplification of this SNP were set at: 
 
Initial denaturation  950C  7 mins 
Denaturation  940C  30 secs 
Annealing   63.10C  30 secs 
Extension   720C  40 secs 
Final extension  720C  5 mins 
Hold   150C  ∞ 
 
A PCR product of 285 bp was produced. Once the size of the product had been confirmed, 
0.5 µl (5 units) of Mva129691, 3 µl of 10x Buffer R and 6.5 µl ddH20 were added to 20 µl 
of PCR product and incubated at 370C for 2 hours. Fermentas supplied both the enzyme 
and buffer. The expected band patterns after digestion are illustrated in figure 2.9. 
30 cycles 
5’TGTATGTGCGAGTATTGGGAAATACTCAATTTCTTTATGGCACCTCATTTGAAATTA
TTTCTTACATAATTTTAAGACTTTCTATGAAGTTTTAGCTTCATGGAAAGAAAAATCAT
GGATTGTTTCCATATCACAAATAGTTAAGATTATGACATTAGATTTCTCTGAGGTCTTT
TTCACTTACAGTGGGTGAGTAGACATATTTCACCTGAGGAAAACAGAAGCTGGGTTTGA
TTTGTGCCTAACTTTCTTTCAGGAATGCCTTCCAAGTATGCCAAGTTGTCA 3' 
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Figure 2.9: Expected band sizes for the different rs3025963 genotypes generated by 
Mva12691 digestion. 
 
2.8.2.3 rs3025966 
 
SNP rs3025966 involves a T→G allele conversion. It too is an RFLP whose “G” allele 
produces an Mva12691 recognition site (5’ “NGCATTC” 3’). The areas of primer binding 
and the position of the SNP on the genomic sequence’s reverse strand are indicated in red 
below:  
 
Forward Primer: 5’ CTACCAGGTGATGCAAAGCA 3’ 
 
Reverse Primer: 5’ CTTACCAAAGGGTCCAGTCG 3’ 
 
The temperature gradient performed on the above primers fluctuated by 50C in both 
directions around a central temperature of 580C. An annealing temperature of 57.80C was 
optimum for the reaction.  
 
 
5’CTACCAGGTGATGCAAAGCAGTTTGGAATTCAGTTCAGATGGTGGCAACCGTATCATT
CTTCCCAGAGAGAAGATGTATGGGCTATTGATGAGATTATCATGACATCTGTGCTTTTCA
ACAGCATTAGTCTTGACTTTACCAATCTTGTGGAGGTCACTCAGTCTCTGGGATTCTACC
TTGGAAATGTTCAGCCATACTGTGGCCACGACTGGACCCTTTGGTAAG 3’ 
                                                        
 
        _________ 285 bp               _________ 285 bp 
   
 _________ 263 bp                                                           _________ 263 bp 
 
 
 
             _________ 22 bp                                                             _________ 22 bp                
 
            Homozygous A/A         Homozygous T/T     Heterozygous A/T 
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The PCR parameters for the reaction were set at: 
 
Initial denaturation  950C  7 mins 
Denaturation  940C  30 secs 
Annealing   57.80C  30 secs 
Extension   720C  40 secs 
Final extension  720C  5 mins 
Hold   150C  ∞ 
 
A 226 bp product was generated using the PCR parameters described above. In order to 
detect which allele of rs3025966 was present in each DNA sample an Mva12691 digest 
was set up following the same protocol used for rs3025963. The expected DNA bands for 
each genotype are shown in figure 2.10. 
 
Figure 2.10: The three possible genotypes at rs3025966 resulting from Mva12691 
digestion.  
 
2.8.2.4 rs362691 
 
The alleles contributing to rs362691 are C or G. For this particular SNP no restriction 
enzyme recognition sequence was present with either allele in place. An ARMS system 
was therefore designed to detect which allele was present in each sample. Two forward 
primers were designed, one detecting the “C” allele and the other detecting the “G” allele. 
The “C” or “G” allele was present at the 3’ terminus of each primer. In addition to the 
30 cycles 
               
          _________ 226 bp                                                           _________ 226 bp 
  
                                          _________ 172 bp               _________ 172 bp 
 
 
 
                                                      _________ 54 bp                 _________ 54 bp                
 
         Homozygous T/T      Homozygous G/G               Heterozygous T/G 
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differing base at each 3’ end, an artificial mismatch was incorporated three bases upstream 
from the 3’ end to increase primer specificity.  
 
In the reverse strand sequence seen below the first 30 underlined bases represent the 
positioning of the forward primers. Due to the C→G change being a weak mismatch, a 
strong second mismatch was required. The “T” allele positioned three nucleotides up from 
the 3’ terminus was converted to a “C” in both forward primers. A common reverse 
primer indicated in light blue below was used for both reactions: 
  
Forward Primer for the “C” allele: 5’AGTTTACACAGTGGAGGAGAGTCATAGCGC 3’ 
Forward Primer for the “G” allele: 5’AGTTTACACAGTGGAGGAGAGTCATAGCGG 3’ 
Common Reverse Primer: 5’ ACTGAAAGTAACCGACTCATTGAGTTCTCC 3’ 
 
A set of control primers was required for the ARMS system in order to confirm whether 
or not each PCR reaction was successful. Control primers should ideally amplify a 
sequence of DNA on another chromosome. The ARMS primers targeted chromosome 
seven and so control primers, which amplified a product of 172 bp on chromosome one 
were used.  
 
A temperature gradient that incorporated the control primers, the common reverse primer 
and the forward primer for the “C” allele was performed. The middle temperature was set 
at 630C and increased and decreased by 50C. An optimum temperature of 63.40C was 
reached. The other PCR parameters were kept the same as those used in previous PCR 
reactions except that the final extension time was increased to seven minutes.  
 
5’AGTTTACACAGTGGAGGAGAGTCATAGTGCTTCTTCCCCAGAAAACTTGGTGAGATG
ACATCTTTAGATATGGCTGTCACTTTAACTTTGACTATCCCTTTTGATTCAATTCTGTC
TCTATTGATTCAAGTATGACTTGAATATGAAGGCAAGTTAAGCACAATAGCATGATGTT
TATTCTTTTTATTTTATTATCAAAAGACCAAAACCTTTCATTTATGTGAATGATATTTG
AAAAAGAGAGCTAATAACAAATATGAAAATGTGGTTTCCAAACTGTCCTAGCCTTCTCT
GACTTTCCTACTTGCCCCAGCTTTTTCTTTTTATGGGAGAACTCAATGAGTCGGTTACT
TTCAGT 3’ 
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Two reactions were carried out per sample, a “C allele” reaction and a “G allele” reaction. 
Both reactions contained the control primers and the common reverse primer but differed 
in the forward primer used. In the case of a C/C homozygote a band of 358 bp as well as 
the 172 bp control band would be amplified from the “C allele” reaction only. The “G 
allele” reaction should only have produced the control band of 172 bp. If however, a 
sample were C/G heterozygous then both reactions should have produced a 358 bp 
product in addition to the control product of 172 bp.  
 
The PCR parameters was set as: 
 
Initial denaturation  950C  7 mins 
Denaturation  940C  30 secs 
Annealing   63.40C  30 secs 
Extension   720C  40 secs 
Final extension  720C  7 mins 
Hold   150C  ∞ 
 
For sequencing purposes of the rs362691 genotypes, another forward primer located 
upstream from the SNP had to be designed. The following primer was designed and used 
to produce one product of 441 bp using the same PCR parameters as above: 
 
    
Upstream Forward Primer:  5’ GTGCCTAACTTTCTTTCAGGAATGCCT 3’ 
 
Common Reverse Primer: 5’ ACTGAAAGTAACCGACTCATTGAGTTCTCC 3’  
 
 
30 cycles 
5’GTGCCTAACTTTCTTTCAGGAATGCCTTCCAAGTATGCCAAGTTGTCAGGAATTTAC
ATCAGCAAGTATTTACCATGCCAGTGAGTTTACACAGTGGAGGAGAGTCATAGTGCTTC
TTCCCCAGAAAACTTGGTGAGATGACATCTTTAGATATGGCTGTCACTTTAACTTTGAC
TATCCCTTTTGATTCAATTCTGTCTCTATTGATTCAAGTATGACTTGAATATGAAGGCA
AGTTAAGCACAATAGCATGATGTTTATTCTTTTTATTTTATTATCAAAAGACCAAAACC
TTTCATTTATGTGAATGATATTTGAAAAAGAGAGCTAATAACAAATATGAAAATGTGGT
TTCCAAACTGTCCTAGCCTTCTCTGACTTTCCTACTTGCCCCAGCTTTTTCTTTTTATG
GGAGAACTCAATGAGTCGGTTACTTTCAGT 3’ 
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2.9 STATISTICAL ANALYSES 
 
The genotyping data generated by means of the techniques described above were 
statistically analysed in order to determine whether any significant results, which might 
indicate a role of the SNP in FAS, were obtained. Once genotyping data had been 
generated for each SNP, genotype and allele frequencies were calculated by simple gene 
counting. The Chi-square test was performed manually and results were then confirmed 
using the “Genetics” package of the computer program called “R”. Due to the manual 
results and those generated by the computer being similar, the computer-generated results 
were used in this study. Computer-based statistical programs were run by Dr. Lize van der 
Merwe of the Biostatistics Unit at the Medical Research Council (MRC) in Cape Town, 
South Africa. R: A language and environment for statistical computing (R Development 
Core Team, 2005) and the R “Genetics” package (Warnes and Leisch, 2005) were utilised 
for the majority of the tests unless otherwise stated. P-values were calculated for all tests. 
A P-value smaller then 0.05 indicated a significant effect.  
 
2.9.1 Allele and Genotype Frequencies 
 
Allele and genotype frequencies were calculated for each ASTN and RELN SNP that data 
had been generated for. Case and control frequencies were calculated separately and 
frequency values were rounded to three decimal places. Rounding results in the frequency 
values do not always add up to one.  
 
2.9.2 Hardy-Weinberg Equilibrium 
 
Hardy-Weinberg equilibrium (HWE) holds in a large randomly mating population where 
migration and natural selection are absent. When a population is in HWE the genotype 
frequencies are expected to remain constant from generation to generation and at any 
locus, the genotype frequencies are a function of allele frequencies. HWE is an important 
phenomenon in genetics and it is the norm for geneticists to check whether observed 
genotypes conform to the expectations of HWE. Any deviations from HWE may suggest 
inbreeding, population stratification or sampling or genotyping error. Where deviations 
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from HWE are present in case individuals (those affected with a particular disease), an 
association between the marker and disease susceptibility might be implied (Wigginton et 
al.  2005).  
 
Chi-square (X2) analysis was used to assess whether the groups demonstrated HWE. 
These calculations were performed manually and then confirmed using the computer 
program “R”. Only the P-values are reported in the dissertation. If the P-value for a 
specific locus is above 0.05, the populations from which the individuals originated is said 
to be in HWE at that locus, whereas any P-values below 0.05 indicate Hardy-Weinberg 
disequilibrium. The equation used to calculate X2 is as follows:  
 
2.9.3 Testing for Association 
 
To test whether a SNP or several SNPs together are associated with the disease three tests 
were performed; the Fisher’s Exact test, haplotype analysis and logistic regression.  
 
2.9.3.1 Fisher’s Exact Test 
 
The Fisher’s Exact test was performed to compare counts of genotypes or alleles at a 
specific locus between cases and controls. Exact P-values calculated and significant 
associations have P-values of less than 0.05 (Fisher, 1922). Fisher’s Exact calculations 
were carried out using the “Genetics” package of the computer program “R.” 
 
2.9.3.2 Haplotype Analysis 
 
Since families were not analysed and some haplotypes cannot be determined with 
certainty, statistical inference was used to calculate the most likely haplotypes. The R 
package used to generate haplotypes for the ASTN and RELN genes was “haplo.stats” 
(Sinnwell and Schaid, 2005). Haplotypes have to be on the same chromosome and for this 
reason ASTN SNPs were analysed together and RELN SNPs were analysed together. The 
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program reported which haplotype for each gene was more common amongst the two 
study groups. A negative haplotype score indicated that the haplotype was more common 
amongst controls whereas a positive haplotype score specified association of the 
haplotype with cases. A global simulated P-value was established by haplo.stats, a P-
value of less than 0.05 suggested there was a significant difference between the haplotype 
frequencies inferred in the cases versus the controls.  
 
2.9.3.3 Logistic Regression 
  
The idea behind a logistic regression model is to describe the differences between two 
groups, in this instance, cases and controls, as a function of other variables, in this 
situation, genotypes at the individual SNPs. The results generated from a logistic 
regression analysis indicate what the probability of being a case or a control is as a 
function of the SNP genotypes. The coefficients of the model are estimated. A negative 
coefficient is associated with being a control whereas a positive estimate is associated 
with being a case.  
 
A global P-value is presented for the model. This is an indication of how well the model 
fits the observed data. A P-value is also presented for each possible term inside the model. 
If the genotype has a P-value less than 0.05, it means that the probability at that genotype 
is independently significantly different from the probability at the baseline genotype for 
that SNP. Independently significant means after adjusting for all other SNPs (in this 
instance) in the model. 
 
A backward stepwise procedure was used to select a logistic regression model. The 
procedure started with a logistic regression model expressing the probability of being a 
case or a control as a function of the genotypes at all the SNPs. The Akaike information 
criterion (AIC) is a measurement that describes how well the model fits the data, the lower 
the AIC value the better the fit of the model. The AIC is used to determine when the best 
model has been reached: the procedure discards terms until the lowest possible AIC is 
reached, indicating the best combination of SNPs that differentiate between cases and 
controls. In this study the initial variables entered to determine the best fitting model were 
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affection status, sex of individual and genotypes at all informative ASTN and RELN SNPs. 
The R package “Mass” (Venables and Ripley, 2002) was used for this analysis.  
 
2.9.4 Linkage Disequilibrium 
 
LD is usually described as being the non-random association of neighbouring alleles. 
These correlations are said to indicate haplotypes that have descended from distinct, 
ancestral chromosomes. A measure of LD therefore denotes whether or not a region of the 
genome cosegregates more often than expected with another region, thus behaving 
dependently or completely independently. Sometimes this association may be due to 
factors like the physical distance between the loci (Reich et al. 2001; Ardlie et al. 2002). 
 
There are several measures of LD, one of which is D’. A D’ value of one would indicate 
complete LD suggesting that genetic markers are tightly linked with one another. A D’ 
value of zero corresponds to no LD between markers. It is however well recognised that 
unlinked alleles may show LD due to population phenomena such as population 
stratification or selection.  
 
The equation used to calculate D’ is: D’= D/Dmax whereby D equals the difference 
between the observed frequency of a two-locus haplotype and the expected frequency if 
the alleles were segregating randomly. An equation used to describe D is as follows: 
 
 Dij = Pij – piqi 
 
Pij is the observed haplotype frequency at locus “i” and locus “j” and piqi represents the 
expected frequencies at locus “i” and locus “j” (Hartl and Clark, 1989). 
 
D is then divided by its maximum possible value, given the allele frequencies at two loci 
(Ardlie et al. 2002). Dmax is the maximum value that D can reach with the given allele 
frequencies (Lenwontin, 1964).  
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“Since P12 = p2q1 – D >0, it follows that D < p2q1. Therefore, the maximum possible value 
of D (Dmax) is given by: Dmax = min( p1q2,  p2q1) whereby “min” is interpreted as “the 
smaller of ” (Hartl and Clark, 1989).” 
 
The calculations of D, Dmax and subsequently D’ were performed using the R “Genetics” 
package. 
 
2.9.5 Post-test Power Calculations 
 
Where a significant association was seen between a genetic marker and disease 
susceptibility, a post-test power calculation was conducted. A post-test power value 
measures a new study’s ability, with the same sample size, to find and label as statistically 
significant, a specific effect. Post-test power depends on the specific effect size observed 
in one’s study. A post-test power value indicates the probability of a true positive 
association, the higher the power value the more likely one is to observe a difference with 
a small effect size. An ideal post-test power value is around 75%, this would suggest that 
the chance of one finding the same significant association in a new study using the same 
sample size is relatively high (Long et al. 1997). 
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CHAPTER 3: RESULTS 
 
3.1 GENOTYPING OF ASTROTACTIN SNPs  
 
The process of determining the cases’ and controls’ genotypes for the ASTN SNPs under 
investigation involved two main steps: PCR followed by restriction enzyme digestion. 
Confirmatory sequencing was done on a few samples to validate the genotypes. The 
following gel pictures and electropherograms represent the findings for SNPs rs6413830, 
rs12118933, rs2228956 and rs11587640. Gel photographs are depicted below in black and 
white, the white illustrating the DNA products. Electropherograms are depicted in colour 
with each base represented by a different colour. 
  
3.1.1 rs6413830 
 
ASTN’s rs6413830 causes a G to A amino acid change. Figure 3.1 illustrates the PCR 
products of 203 bp incorporating this SNP. Figure 3.2 depicts the visual genotyping 
results after AluI digestion of the 203 bp products. Sequencing was performed to confirm 
the results observed through AluI digestion. These sequencing results are illustrated as a 
series of electropherograms in figure 3.3. 
       PCR Products 
 
 
 
 
 
 
 
 
 
 
Figure 3.1: 203 bp PCR products encompassing ASTN’s rs6413830 SNP run on a 3% 
agarose gel. Lane 1: HyperLadder V. Lanes 2-9: PCR products from case and control 
samples. Lane 10: Negative control (no DNA). 
  1         2       3         4       5        6        7        8       9       10    
203 bp 
250 bp 
200 bp 
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AluI Digestion 
 
 
 
Figure 3.2: Digestion of rs6413830 PCR products with AluI viewed on a 4% agarose gel.  
Lane 1: HyperLadder V. Lane 2: Uncut PCR product (203 bp). Lane 3: Positive G/A 
heterozygote. Lane 4: Positive A/A homozygote. Lane 5: Positive G/G homozygote. 
Lanes 6-11: Control sample digests. Lane 12: Negative control (no DNA). “Positive” 
genotypes were confirmed by sequencing. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1      2      3      4      5       6      7      8      9     10    11     12 
200 bp 
125 bp 
203 bp 
 
 129 bp          
  74 bp  75 bp 
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     Sequencing Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3: Electropherograms (forward strands) confirming genotyping results obtained 
from AluI enzyme digestion of rs6413830. The arrows indicate the SNP position. A/A 
homozygote: Control sample NPC004 (a). G/G homozygote: Control sample NPC018 
(b). G/A heterozygotes: DNA samples sequenced were NPC021 and NPC027 
respectively (c & d). 
 
(a) (b) 
(c) (d) 
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3.1.2 rs12118933 
 
ASTN’s rs12118933 involves a G to C base alteration and is responsible for an amino acid 
change. Figure 3.4 depicts PCR products of 593 bp within which the SNP is included. 
Figure 3.5 illustrates the various genotypes indicated by the different banding patterns 
produced after the PCR products were digested with MspI. Electropherograms confirming 
the genotype results produced by MspI digestion are represented in Figure 3.6  
 
 
               PCR Products 
 
Figure 3.4: PCR products of 593 bp encompassing ASTN’s rs12118933 SNP run on a 3% 
agarose gel. Lane 1: 1 Kb Plus DNA Ladder. Lanes 2-9: PCR products for case and 
control samples. Lane 10: Negative control (no DNA). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1       2        3       4       5       6       7       8       9      10  
593 bp 
650 bp 
500 bp 
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MspI Digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Digestion of ASTN’s rs12118933 PCR products with MspI, samples viewed 
on a 4% agarose gel. Lane 1: 1 Kb Plus DNA Ladder. Lane 2: Uncut PCR product (593 
bp). Lane 3: Positive G/G homozygote. Lane 4: Positive G/C heterozygote. Lanes 5-10: 
Control sample digests. Lane 11: Negative control (no DNA). No C/C homozygotes were 
identified in either cases or controls. “Positive” genotypes were confirmed by sequencing.  
       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    1       2       3      4       5      6       7      8       9     10     11 
650 bp 
100 bp 
593 bp 
512 bp 
81 bp (very 
faint band) 
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       Sequencing Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
  Forward               Reverse 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                            
   Forward        Reverse 
 
Figure 3.6: Electropherograms confirming genotyping results for rs12118933. Arrows 
indicate SNP position. G/G homozygote: Forward (a) and reverse (b) strands of sample 
NPC001 indicating a “G” and reverse compliment “C” allele respectively at the SNP 
position. G/C heterozygote: Forward (c) and reverse (d) strands of sample NPF017. At 
position “N”, the forward strand indicates a G/C heterozygote (black and blue double 
peak) and the reverse strand confirms this.  
 
(a) (b) 
(c) (d) 
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3.1.3 rs2228956 
 
Rs2228956 involves a T to C base change in the ASTN gene. Figure 3.7 below illustrates 
the PCR products of 381 bp incorporating the SNP. Once the size of the PCR products 
had been confirmed they were digested with HhaI to generate different band patterns 
depicting the various genotypes (figure 3.8). Figure 3.9 illustrates the sequencing results 
produced of the various genotypes.  
 
 
      PCR Products 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.7:  381 bp PCR products encompassing ASTN’s rs2228956 SNP run on a 3% 
agarose gel. Lane 1: HyperLadder V. Lanes 2- 7: PCR products for case and control 
samples. Lane 8: Negative control (no DNA). 
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       HhaI Digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Digestion of ASTN’s rs2228956 PCR products with HhaI viewed on a 4% 
agarose gel. Lane 1: HyperLadder V. Lane 2: Uncut PCR product (381 bp). Lane 3: 
Positive T/C heterozygote. Lane 4: Positive C/C homozygote. Lane 5: Positive T/T 
homozygote. Lanes 6-11: Control sample digests. Lane 12: Negative control (no DNA). 
“Positive” genotypes were confirmed by sequencing. 
 
 
     Sequencing Results 
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          Forward                  Reverse   
                        
 
 Forward                                                                  Reverse 
 
Figure 3.9: Sequencing results confirming the rs2228956 genotypes. The arrows indicate 
the SNP position. T/T homozygote: Forward (a) and reverse (b) strands of control sample 
NPC029. The forward strand indicates a T/T homozygote and the reverse strand confirms 
this by showing a single “A” allele peak (reverse compliment) at the same point. C/C 
Heterozygote: Forward (c) and reverse (d) strands of control sample NPC022. The 
forward strand shows a clear “C” allele and the reverse strand indicates the compliment 
“G” allele. T/C Heterozygote: Forward (e) and reverse (f) strands of control sample 
NPC059. The forward strand indicates a T/C heterozygote and the reverse strand confirms 
this by showing a green (“A”) and black (“G”) double peak at the same point. 
(f) (e) 
(c)  (d) 
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3.1.4 rs11587640 
 
ASTN’s rs11587640 consists of a G to T base change. Figure 3.10 shows the generated 
PCR products (172 bp) incorporating the SNP. Figure 3.11 is a gel picture that visualises 
the unfavourable results obtained after SbfI digestion of the PCR products. Due to the 
digestion problems this SNP was abandoned. 
 
 
            PCR Products 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: PCR products of 172 bp in size encompassing ASTN’s rs11587640 SNP run 
on a 3% agarose gel. Lane 1: HyperLadder V. Lanes 2-12: PCR products for case and 
control samples. Lane 13: Negative control (no DNA). 
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     SbfI Digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: 4% agarose gels showing digestion of ASTN’s rs11587640 PCR products 
with SbfI. Gel (a) shows digestion of case samples whereas gel (b) shows digestion of 
control samples. For both gels, lane 1: HyperLadder V. Lane 2: Uncut PCR product of 
172 bp. The last lane on each gel contains a negative control (no DNA). The majority of 
samples abnormally appear to be G/T heterozygotes with the sample in lane 9(b) 
representing a partial digest. Due to these problems and failure to optimise the detection 
method this SNP was abandoned. 
 
 
The PCR reaction for rs11587640 was successful in amplifying the desired 172 bp product 
from each sample. However, identification of the different alleles by SbfI digestion 
appeared to be problematic in that ambiguous results were obtained. SbfI manufactured by 
   1    2    3     4    5     6    7    8    9   10   11  12  13  14   15  16  17  18  19  20  
175 bp 
125 bp 
(b) 
172 bp 
130 bp 
   1      2      3       4      5      6     7       8      9     10    11   12    13    14   
172 bp 
130 bp 
175 bp 
   125 bp 
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New England Biolabs was used. This enzyme failed to produce feasible results even after 
16 hour digestions as recommended by the manufacturer. On a 4% agarose gel, SbfI 
appeared to have cut, however, G/T heterozygotes were seen for all cases and the majority 
of controls. A sample representing possible incomplete digestion was also observed (lane 
9 of figure 3.11(b)). This is unlikely to be a true reflection of the 157 individuals 
genotyped (112 controls and 45 cases). In a population, one would expect to locate some 
definite homozygotes, G/G or T/T or both. When contacted, the manufacturers stated that 
SbfI is strongly inhibited by salts such as residual salts from commercial DNA purification 
kits.  
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3.2 GENOTYPING OF REELIN SNPs  
 
Much like the protocols and processes performed involving the ASTN SNPs, the processes 
performed on the RELN SNPs involved PCR followed by restriction enzyme digestion and 
confirmatory sequencing. One another technique was employed for one of the RELN 
SNPs and that was the specialised PCR reaction known as ARMS. The following gel 
pictures and electropherograms represent the findings for SNPs rs607755, rs3025963, 
rs3025966 and rs362691.  
 
3.2.1 rs607755 
 
RELN’s rs607755 involves the alleles T or C. Figure 3.12 illustrates the PCR products 
within which the SNP is present. Figure 3.13 is a gel picture depicting the genotyping 
results obtained after digestion of the PCR products with PvuII. Figure 3.14 is a series of 
electropherograms that were generated to confirm the genotyping findings obtained by 
enzyme digestion. 
 
              PCR Products 
 
Figure 3.12: 529 bp PCR products encompassing RELN’s rs607755 SNP run on a 3% 
agarose gel. Lane 1: 1 Kb Plus DNA Ladder. Lanes 2- 9: PCR products for case and 
control samples. Lane 10: Negative control (no DNA). 
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PvuII Digestion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Digestion of RELN’s rs607755 PCR products with PvuII, products viewed 
on a 4% agarose gel. Lane 1: I Kb Plus DNA Ladder, Lane 2: Uncut PCR product (529 
bp), Lane 3: Positive T/C heterozygote. Lane 4: Positive C/C homozygote. Lane 5: 
Positive T/T homozygote. Lanes 6-12: Control sample digests. Lane 13: Negative control 
(no DNA). “Positive” genotypes were confirmed by sequencing. 
 
 
              Sequencing Results 
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Forward            Reverse 
 
 
            Forward      Reverse 
 
Figure 3.14: Sequencing results confirming the three genotypes obtained for rs607755. 
C/C Homozygote: Forward (a) and reverse (b) strands of NPC038. A single blue peak 
indicative of a “C” allele is evident on the forward strand and a single black peak 
indicative of a “G” allele is seen on the reverse strand (arrows indicate SNP position).  
T/T Homozygote: Forward (c) and reverse (d) strands of sample NPC051. The Forward 
strand indicates single “T” allele at the SNP position and the reverse strand confirms this 
by showing a single reverse compliment “A” allele at the same position. C/T 
Heterozygote: Forward (e) and reverse (f) strands of NPC104. A red and blue double 
peak, indicative of both “C” and “T” alleles can be seen on the forward strand and a 
complimentary black and green double peak, illustrating the presence of both “G” and 
“A” alleles is present on the reverse strand. 
(c) (d) 
(e) (f) 
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3.2.2 rs3025963 
 
Rs3025963 involves an A to T base change. Figure 3.15 below is a gel picture that 
illustrates the 285 bp PCR products incorporating rs3025963. Figure 3.16 depicts the 
results obtained after digestion of the PCR products with Mva12691. SNP rs3025963 
proved uninformative, no variation was seen in either cases or controls after 60 controls 
and 25 cases were typed. No further analysis could be carried out on this marker. 
 
 
       PCR Products 
 
Figure 3.15: PCR products of 285 bp in size encompassing RELN’s rs3025963 SNP run 
on a 3% agarose gel. Lane 1: HyperLadder V. Lanes 2-9: PCR products for case and 
control samples. Lane 10: Negative control (no DNA). 
 
 
 
 
 
 
 
 
 
 
 
 
              
285 bp 300 bp 
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Mva12691 Digestion 
 
 
Figure 3.16: Digestion of RELN’s rs3025963 PCR products with Mva12691, products 
viewed on a 4% agarose gel. Lane 1: HyperLadder V, Lane 2: Uncut PCR product (285 
bp), Lanes 3-8: Control sample digests of 263 bp in size (indicating the presence of the 
“A” allele). The 22 bp fragment would have run off the gel. Lane 9: Negative control (no 
DNA).  
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3.2.3 rs3025966 
  
RELN’s rs3025966 involves a T or G allele. Figure 3.17 illustrates a gel picture of the 
PCR products that incorporate the SNP. Figure 3.18 illustrates the results obtained after 
Mva12691 digestion of the 226 bp PCR products. On digestion of RELN marker 
rs3025966 the same problem observed in rs3025963 occurred. Rs3025966 proved to be 
uninformative. Due to no allelic variation being seen in either cases or controls no further 
analysis was carried out on this SNP.  
 
 
                     PCR Products 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.17: 226 bp PCR products encompassing RELN’s rs3025966 SNP run on a 3% 
agarose gel. Lane 1: HyperLadder V. Lanes 2-8: PCR products for case and control DNA 
samples. Lane 9: Negative control (no DNA). 
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          Mva12691 Digestion 
 
 
Figure 3.18: Digestion of RELN’s rs3025966 PCR products with Mva12691, products 
viewed on a 4% agarose gel. Lane 1: HyperLadder V. Lane 2: Uncut PCR product (226 
bp). Lanes 3-16: Case samples after digestion, note cutting of the PCR products has not 
occurred indicating the absence of the “G” allele at the SNP position. Lane 17: Negative 
control (no DNA). 
 
 
Digestion of rs3025966 required the same Mva12691 enzyme used in rs3025963 
digestion. Based on the results seen in figure 3.16 it was evident that the enzyme was 
indeed cutting as a change in size from 285 bp to 263 bp was observed. In figure 3.18 no 
enzymatic cleaving occurred indicating the presence of the “T” allele in all samples.  
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3.2.4 rs362691 
 
Rs362691 is not an RFLP and so an ARMS system was employed. Figure 3.19 illustrates 
the results obtained from the ARMS reaction.  In order to confirm the results obtained by 
ARMS, sequencing was conducted. However, prior to sequencing, new PCR products 
amplified by only one set of primers (no control primers) had to be generated. Figure 3.20 
illustrates the PCR products used for sequencing and figure 3.21 depicts the sequencing 
results obtained. 
        ARMS PCR System  
 
 
Figure 3.19: PCR products from RELN’s rs362691 ARMS system shown on a 3% 
agarose gel. Lane 1: 1 Kb Plus DNA Ladder. Lanes 2 and 3: Control sample NPC067, 
C/G heterozygote (lane 2= products from “C” allele reaction & lane 3= products from “G” 
allele reaction). Lanes 4 and 5: Control sample NPC005, C/C homozygote (lane 4= 
products from “C” allele reaction & lane 5= products from “G” allele reaction). Lanes 6 
and 7: Control sample NPC107, a C/G heterozygote (lane 6= products “C” allele reaction 
& lane 7= products from “G” allele reaction). Lanes 8 and 9: Control sample NPC 001, a 
C/C homozygote (lane 8= products from “C” allele reaction & lane 9= products from “G” 
allele reaction). Lane 10: Negative control for the “C” allele Master Mix (no DNA).  
Lane 11: Negative control (no DNA) for the “G” allele Master mix. 
  1       2       3       4       5       6       7      8       9      10    11 
     NPC067      NPC005    NPC107   NPC001 
400 bp 
200 bp 
358 bp 
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Only C/C homozygotes and C/G heterozygotes were observed in the cases and controls 
for rs362691. In order to confirm the results obtained by the ARMS PCR, sequencing of 
the two genotypes was carried out.  
 
 
     Sequencing Results 
 
      
   PCR Products for Sequencing 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.20: PCR products of 441 bp generated for the purpose of rs362691 sequencing, 
run on a 3% agarose gel  
 
 
This SNP proved to be problematic during sequencing. Despite electropherogram data 
being generated for the samples sequenced, the sequencing results were obscured by what 
appeared to be a contaminating sequence. On the 3% agarose gels, only one band was 
visible for PCR products (figure 3.20) it therefore did not appear as though any other 
region of the genome was being amplified. To rule out experimental error with the cycle 
sequencing and the product purification steps, the SNP was sequenced on three different 
occasions. For each sequencing run new PCR products were amplified. All three attempts 
produced electropherograms that had the same in appearance. Figure 3.21 illustrates the 
sequencing results obtained. 
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              Sequencing Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     
               
Forward       Reverse 
 
Figure 3.21:  Electropherograms of the forward and reverse strands of control sample 
NPC005, C/C homozygote for rs362691 (see figure 3.19). On the forward strand (a), the 
red peak below the blue “C” allele peak at the site of the SNP (indicated by the arrow) 
appears to be caused by the neighbouring “T” allele. The reverse strand (b) indicates an 
expected black “G” allele peak at the SNP position. The blue peak beneath the “G” allele 
also appears to be caused by the neighbouring “C” allele. 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) (b) 
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  Forward                     Reverse 
 
                  
 
Forward       Reverse 
Figure 3.22: Electropherograms of rs362691 C/G heterozygotes. The forward (c) and 
reverse (d) strands of sample NPC067 and the forward (e) and reverse (f) strands of 
NPC107. At the position of the SNP indicated by the arrow on the forward strands (c & 
e), a blue peak is visible with a black peak underneath it. The red peak overlapping the 
blue peak most probably results from the “T” allele to the right of the SNP. The reverse 
strands (d & f) show similar results with a blue peak as well as a black peak being present 
at the SNP site.  
(f) (e) 
(c) (d) 
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Based on the sequencing data obtained from rs362691, it is evident that the quality of the 
electropherograms is not ideal and it appears as though the signals from the different bases 
are being carried over onto the neighbouring bases. As mentioned previously, sequencing 
was carried out on three separate occasions using fresh PCR products every time and on 
all three occasions the same peak pattern was seen in each electropherogram. It is possible 
that the primer could have been defective in that there were two populations of 
oligonucleotides in that primer mix but one population could have been one base shorter 
than the other. 
 
If one compares a sequenced C/C homozygote (figure 3.21) to a sequenced C/G 
heterozygote (figure 3.22) it is evident that the underlying black “G” allele peak present in 
the heterozygote samples is absent in the C/C homozygote electropherograms. This 
therefore confirms that the samples NPC067 and NPC107 are indeed C/G heterozygotes 
as shown by the ARMS PCR system.  
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3.3 STATISTICAL ANALYSES 
 
3.3.1 Genotype and Allele Frequencies 
 
Table 3.1: Genotype and allele frequencies for ASTN markers: cases and controls 
 
          CASES                 CONTROLS  
SNP Genotype/allele      f n                f n 
rs6413830 G/G 
G/A 
A/A 
Total: 
 
G 
A 
Total: 
0.644 
0.333 
0.022 
 
 
0.811 
0.189 
29 
15 
1 
45 
 
73 
17 
90 
0.589 
0.357 
0.053 
 
 
0.768 
0.232 
66 
40 
6 
112 
 
172 
52 
224 
      
rs12118933 G/G 
G/C 
C/C 
Total: 
 
G 
C 
Total: 
0.956 
0.044 
0.000 
 
 
0.978 
0.022 
 
43 
2 
0 
45 
 
88 
2 
90 
0.973 
0.027 
0.000 
 
 
0.987 
0.013 
109 
3 
0 
112 
 
221 
3 
224 
      
rs2228956 C/C 
T/C 
T/T 
Total: 
 
C 
T 
Total: 
0.822 
0.178 
0.000 
 
 
0.911 
0.089 
37 
8 
0 
45 
 
82 
8 
90 
0.830 
0.152 
0.018 
 
 
0.906 
0.094 
93 
17 
2 
112 
 
203 
21 
224 
 
n, number of observations for genotypes or alleles;  f, frequency 
 
 
On superficial scrutiny the results depicted in the table above appear to show that there is 
no striking difference between the case and control groups in the frequencies of each 
ASTN SNP. Allele and genotype frequencies for both groups are very similar. 
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Table 3.2: Genotype and allele frequencies for RELN markers: cases and controls 
 
          CASES             CONTROLS  
SNP Genotype/allele          f n          f n 
rs362691 C/C 
C/G 
G/G 
Total: 
 
C 
G 
Total: 
0.978 
0.022 
0.000 
 
 
0.989 
0.011 
44 
1 
0 
45 
 
89 
1 
90 
0.902 
0.098 
0.000 
 
 
0.951 
0.049 
 
101 
11 
0 
112 
 
213 
11 
224 
      
rs607755 C/C 
T/C 
T/T 
Total: 
 
C 
T 
Total: 
0.489 
0.333 
0.178 
 
 
0.344 
0.656 
22 
15 
8 
45 
 
59 
31 
90 
0.313 
0.545 
0.143 
 
 
0.585 
0.415 
 
35 
61 
16 
112 
 
131 
93 
224 
 
n, number of observations for genotypes or alleles;  f, frequency 
 
On initial visual scrutiny table 3.2 shows similar frequencies for cases and controls 
regarding rs362691. There is a clear difference however, between the cases and the 
controls for rs607755; the T/C genotype accounts for the majority of the 112 controls      
(n = 61) followed by the C/C genotype (n = 35) and lastly the T/T genotype (n = 16). 
However, in the 45 cases the most common genotype was C/C (n = 22) followed by the 
T/C genotype (n = 15) and finally the T/T genotype (n = 8). Association tests were 
performed to confirm the above observations.  
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3.3.2 Hardy-Weinberg Equilibrium 
 
The Hardy-Weinberg test was done to see whether the study groups conformed to HWE at 
the various loci and to detect if any sampling or genotyping error were present. 
 
Table 3.3: P-values for the HWE test in cases and controls for ASTN 
 
Marker Cases Controls 
rs6413830 1.000 1.000 
rs12118933 1.000 1.000 
rs2228956 0.238 1.000 
 
 
Table 3.4: P-values for the HWE test in cases and controls for RELN 
 
Marker Cases Controls 
rs362691 1.000 1.000 
rs607755 0.245 0.0975 
 
 
The P-values generated for the HWE tests for the ASTN and RELN SNPs are all above 
0.05. It is therefore unlikely that there are any sampling or genotyping errors, inbreeding 
or population stratification. These results indicate that the study groups together form a 
fair representation of the Northern Cape Coloured community with respect to these two 
genes. 
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3.3.3 Association Testing  
 
The tables below indicate the results generated from the Fisher’s exact test, which looked 
for association between the polymorphic variants and the susceptibility to FAS.  
 
Table 3.5: P-values for association tests for cases versus controls at the allelic and 
genotypic level for ASTN 
 
Marker Allelic Association Genotypic Association 
rs6413830 0.453 0.747 
rs12118933 0.627 0.625 
rs2228956 1.000 0.904 
 
The P-values obtained for the allelic and genotypic associations presented in table 3.5 are 
all above 0.05 and indicate that there are no significant associations. 
 
Table 3.6: P-values for association tests for cases versus controls at the allelic and 
genotypic level for RELN 
    
Marker Allelic Association Genotypic Association 
rs362691 0.190 0.181 
rs607755 0.254 0.049 
 
Table 3.6 lists the P-values obtained for the allele and genotype tests performed on 
RELN’s rs362691 and rs607755. Rs362691 shows no association with the disease at either 
the allelic or genotypic level, rs607755 on the other hand has a result of 0.049 (P<0.05) 
indicating significant genotypic association.  
 
A post-test power calculation was carried out for rs607755’s significant result; a post-test 
power value of 0.58 was obtained. This value suggests a moderate chance (58%) of one 
observing the significant effect in a new study using the same sample size.  
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3.3.4 Haplotype Analysis 
 
The haplotype analysis involved analysing whether any of the inferred haplotypes where 
significantly associated with either the case or control groups. Tables 3.7 and 3.8 list the 
results. 
 
Table 3.7: Comparison of FAS cases versus controls: Haplotype Scores, P-values and 
Haplotype Frequencies (hf) for ASTN 
 
Global P-value = 0.9  
  
rs6413830 
 
rs12118933 
 
rs2228956 Hap. Score P-value Control hf Case hf 
1 A G C -0.762 0.472 0.210 0.170 
2 A G T -0.417 0.770 0.020 0.020 
6 G G T -0.182 0.826 0.070 0.060 
5 G G C 0.709 0.473 0.680 0.730 
3 G C C 0.000 0.000 0.010 0.010 
4 G C T 0.000 0.000 0.000 0.010 
 
A negative Hap-score would suggest that a particular inferred haplotype is associated with 
controls (i.e. is more common amongst controls) whereas a positive Hap-score would 
indicate the inferred haplotype is associated with cases.  
 
The analysis revealed that the inferred GGC haplotype (harbouring alleles, rs6413830^G, 
rs12118933^G and rs2228956^C) is the most common haplotype for the ASTN gene as it 
is predicted to be present in 68% of controls and 73% of cases. The global P-value 
generated for ASTN is 0.9, indicating that there is no significant difference between the 
cases and controls regarding the inferred haplotypes of the ASTN gene. In addition, each 
Hap-score has a P-value of more than 0.05 and so none of the inferred haplotypes can be 
said to be associated with either cases or controls.  
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Table 3.8: Comparison of FAS cases versus controls: Haplotype Scores, P-values and 
Haplotype Frequencies (hf) for RELN 
 
Global P-value = 0.269 
 
The global P-value obtained for RELN’s inferred haplotype analysis is 0.269 indicating no 
significant difference between the two study groups.  The most common haplotype was 
CC (alleles rs362691^C and rs607755^C) with 56.7% of controls and 65.6% of cases 
having this inferred haplotype. None of the inferred haplotypes can be said to be 
associated with either cases or controls as all P-values are above 0.05. 
 
3.3.5 Logistic Regression 
 
The final logistic regression model contained the following variables: the two RELN SNPs 
and affection status (FAS or control). All the ASTN SNPs were discarded and there was no 
difference between sex of the cases and controls.  
 
A significant overall P-value of 0.032 was obtained for the model, which indicates that the 
whole model with all the predictors is significant in distinguishing between the cases and 
the controls. Table 3.9 gives the estimates of the coefficients in the model, their standard 
errors and corresponding P-values for the logistic regression model of cases versus 
controls.  
 
 
 
 
 
 
 rs362691 rs607755 Hap. Score  P-value Control hf Case hf 
4 G T -1.176 0.284 0.032 0.011 
2 C T -0.798 0.444 0.383 0.333 
1 C C 1.412 0.144 0.567 0.656 
3 G C - - 0.017 0.000 
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Table 3.9: Final logistic regression model for FAS cases versus controls  
 
P-value for entire model = 0.032 
Coefficients Estimate Standard Error P-value 
Intercept -0.425 0.274 0.121 
    
RELN rs607755 C/C 0.000 - - 
RELN rs607755 C/T -0.890 0.399 0.026 
RELN rs607755 T/T -0.131 0.520 0.802 
    
RELN rs362691 C/C 0.000 - - 
RELN rs362691 C/G -1.490 1.071 0.164 
 
Table 3.9 indicates that the C/T and T/T genotypes from rs607755 and the C/G genotype 
from rs362691 are all associated with being a control individual. From the individual P-
values for each genotype however, only rs607755’s C/T has a P-value of less than 0.05.  
 
This suggests that the probability of being a FAS case with the C/T genotype is 
independently significantly different from the baseline genotype C/C and is more likely to 
be found amongst control subjects thus conferring a protective role against FAS. This 
supports the genotypic association seen between this marker and the disease in table 3.6.  
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3.3.6 Linkage Disequilibrium 
 
3.3.6.1 Astrotactin Markers 
 
Out of the four ASTN SNPs, genotypic information was gained for only three. The 
pairwise linkage disequilibrium heat map below indicates the degree of linkage between 
the SNPs based on the results generated by the control group. ASTN1a = rs6413830, 
ASTN1b = rs12118933 and ASTN1c = 2228956. The distance between ASNT1a and 
ASTN1c is 31.3kb. The colour key below indicates D’ values. High LD is seen between 
ASTN1a and ASTN1b (D’= 0.978). ASTN1b and ASTN1c are also in very high LD       
(D’= 0.946) whereas ASTN1a and ASTN1c are in low LD (D’= 0.018) with each other.  
Pairwise LD
Physical Length:31.3kb
*
  AS
TN1a
*
  AS
TN1b
*
  AS
TN1c
0.1 0.3 0.5 0.7 0.9
Color Key
 
 
Figure 3.23: A heat map indicating the degree of LD between the ASTN SNPs.  
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3.3.6.2 Reelin Markers 
 
Of the four SNPs chosen in the RELN gene, two of them proved to be monomorphic and 
so informative data was collected for two SNPs, rs362691 and rs607755. The heat map 
below indicates the degree of linkage disequilibrium between markers RELNa (rs362691) 
and RELNb (rs607755) based on the control samples’ results. The distance between the 
SNPs is 138.8kb. The two SNP are in moderate LD (D’= 0.396) with each other. 
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Figure 3.24: A heat map indicating the degree of LD between the RELN SNPs. 
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CHAPTER 4: DISCUSSION 
 
4.1 PROJECT FINDINGS 
 
In this particular FAS genetics study the focus was on genes involved in the neuronal 
migratory pathway. Up until now, the few studies that have been conducted on the 
genetics behind FAS and other alcohol related birth defects have focussed on alcohol’s 
metabolic pathway. It is well known that alcohol affects the process of neuronal migration 
in the developing brain and so this pathway, and the genes involved, appeared to be 
suitable for investigation in a case-control association study on FAS. 
 
Astrotactin and Reelin were selected as candidate genes based on the crucial role they 
both play in neuronal migration. Also, the phenotypic presentation of ASTN and RELN 
defects are similar to those seen in FAS individuals.  
 
4.1.1 Laboratory Results 
 
The majority of the laboratory analysis conducted on the four ASTN and four RELN SNPs 
was successful. PCR reactions were successful and the desired products were obtained in 
all instances. Problems arose in one of the ASTN SNPs (rs11587640) that required a 
highly sensitive restriction enzyme, SbfI, for digestion. Residual salts present in the DNA 
(a result of the commercial DNA extraction kit used) inhibited the enzyme. An 
isoschizomer for SbfI was located but was not available in South Africa. It was therefore 
decided to abandon this SNP from further analysis.  
 
Another problem encountered was the discovery of uninformative SNPs. Two of the 
RELN SNPs chosen for investigation, rs3025963 and rs3025966, proved to be 
uninformative with no genetic variation seen at all in either cases or controls. These 
uninformative SNPs were reported on the Ensembl database as being “suspected’ with no 
frequency data ever having been generated and recorded. Both these SNPs were 
considered coding, non-synonymous SNPs. Most researchers select non-synonymous 
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SNPs over those considered synonymous or intronic, as they are more likely to have an 
effect on the functionality of the protein. RELN’s rs3025966 was selected as a SNP for 
investigation in April 2005, in August of that year it had been removed from the RELN 
SNP list on Ensembl and then two months later it had been placed back on the list but on 
this occasion it was referred to as a “stop gained SNP, (Y/*).” A stop gained SNP is one 
where the allele change forms a stop codon thus terminating translation. This emphasises 
the importance of validated data being recorded and available for public access through 
databases. It should be a guideline for future studies that only SNPs that have been 
validated, and for which frequency data have been generated, should be used 
experimentally. Alternatively, researchers could identify de novo SNPs in the populations 
on which the studies are done, especially if they have not previously been well studied.  
 
4.1.2 Comparison of Genotype and Allele Frequencies in Different Populations 
 
Genotype and allele frequencies were calculated for those SNPs that had sufficient 
genotypic information. The T/C genotype for RELN’s rs607755 was significantly more 
common in the control group when compared to the case group (0.545 vs. 0.333). 
Although this SNP gives rise to a missense mutation (leucine to serine), no known 
functional difference has been attributed to it. The change from leucine to serine involves 
the protein changing from being uncharged to charged polar which could indicate a likely 
functional effect. It is not clear how the heterozygous state is associated with 
protectiveness against FAS but one possible explanation would be heterozygous 
advantage. However, the relevance of such an explanation to a monomeric extracellular 
protein is not obvious.       
 
The allele and genotype frequencies calculated for the various SNPs are important and 
interesting data that can be entered into a database such as Ensembl or the National Center 
for Biotechnology Information’s (NCBI’s) SNP database known as  “dbSNP.” Table 4.1 
indicates genotype and allele frequencies recorded on Ensembl for some of the ASTN and 
RELN SNPs as well as the frequency data generated from this study. HapMap data is 
available for all five markers investigated in this study. The HapMap frequency data is 
comparable to the Ensembl data (http://www.hapmap.org).  
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Table 4.1: Comparison of genotype and allele frequencies in three different populations 
for some of the ASTN and RELN SNPs investigated 
 
                      Population Frequencies 
Gene SNP and strand 
alleles 
correspond to 
Genotype/ 
Allele  
African 
American* 
 
(n = 23) 
European, 
American 
Descent* 
(n = 24) 
South African, 
Northern Cape 
Coloured ** 
(n = 112) 
ASTN rs6413830 G/G 0.435 0.292 0.589 
 (forward strand) G/A 0.478 0.583 0.357 
  A/A 0.087 0.125 0.053 
  A 0.326 0.417 0.232 
  G 0.674 0.583 0.768 
      
 rs2228956 C/C 0.591 0.750 0.830 
 (forward strand) T/C 0.318 0.208 0.152 
  T/T 0.091 0.042 0.018 
  C 0.750 0.854 0.906 
  T 0.250 0.146 0.094 
      
RELN rs362691 C/C 0.826 0.750 0.902 
 (reverse strand) C/G 0.174 0.167 0.098 
  G/G 0.000 0.083 0.000 
  C 0.913 0.833 0.951 
  G 0.087 0.167 0.049 
      
 rs607755 C/C 0.348 0.250 0.313 
 (reverse strand) T/C 0.174 0.625 0.545 
  T/T 0.478 0.125 0.143 
  C 0.435 0.562 0.585 
  T 0.565 0.438 0.415 
* Taken from the Ensembl database 
** Based on controls only  
 
In certain instances only two of the three possible genotypes were observed (tables 3.1 and 
3.2). Where genotype and allele data for other populations is available, one can compare 
whether or not the genotypes not observed in this study were reported in other populations 
and at what frequency. Genotype and allele frequencies were available for African 
Americans and Americans of European descent for markers rs2228956 and rs362691. 
Although genotype and allele frequencies do vary amongst different populations, the 
comparative values merely give an indication of what one could expect from a population 
that is considered admixed and comprised of African and European ancestry. From table 
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4.1 it is evident that the T/T genotype of rs2228956 occurs at a low frequency, 0.091 and 
0.042 in the other two populations. This would indicate that the frequency findings from 
this study follow the genotype distribution in the African American and European 
populations.  Like the Coloured population, the G/G genotype for rs362691was not 
observed in the African American population and occurs at a low frequency of 0.083 in 
the European population. These comparative frequencies support the likelihood that the 
G/G genotype will not be observed in the Northern Cape Coloureds, given the sample 
size. If one had a larger sample size, one might locate the genotype at a very low 
frequency. In the Coloured population the “G” allele occurs at a frequency of 0.049 and so 
one would expect a G/G frequency of (0.049)2 = 0.002. Therefore, if the population was in 
HWE and the sample size was large enough one would expect to see the G/G genotype.   
 
4.1.3 Impact of Admixture on Identifying Genetic Susceptibility Factors 
 
The population used for this study is considered to be an admixed one. Admixture arises 
from interbreeding between different populations. Admixed populations can be most 
useful in candidate gene studies as they tend to exhibit different disease and marker allele 
frequencies compared to the parental populations (Wright et al.  1999). The process of 
admixture generates LD between both linked and unlinked loci that differ in allele 
frequencies in the parental populations. The degree of difference between the parental 
allele frequencies, the level of admixture and the time since admixture occurred are all 
factors affecting admixture linkage disequilibrium (ALD). Admixture is a continuous 
process that tends to create disequilibrium that decays rapidly for unlinked markers 
(within two to four generations) but slowly for linked markers. Admixture is considered a 
continuous process in two ways, internally and externally. Internal admixture involves 
random mating between members of the same admixed population whereas external 
admixture results from random mating between members of an admixed population and 
members of different populations. Admixed populations are of particular usefulness in LD 
mapping studies (Halder and Shriver, 2003).  
 
One of the most significant disadvantages of using an admixed population is population 
stratification. It is unlikely that an admixed population will consist of individuals of the 
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same admixture levels thus resulting in population stratification, which can cause false-
positive associations between genetic markers and a given disease. It is advised that 
researchers using admixed populations in their investigations correct for admixture in 
order to prevent false-positive associations from arising. However, in order to correct for 
admixture, it is important for a researcher to know the proportional contributions of the 
parental populations and also to know the level of stratification caused by admixture in the 
population under investigation (Halder and Shriver, 2003).  
 
With regards to the current investigation involving the Northern Cape Coloured 
population, one is unable to state the contribution of the ancestral populations as the 
admixed population arose hundreds of years ago from many different populations 
including the European, Khoisan and Central African black immigrants. Also, admixture 
in this case is an ongoing process and so the degree of it cannot be assessed. For these 
reasons this study did not statistically correct for admixture effects and so population 
stratification could have been a confounding factor.  
 
In order to rule out population stratification, inbreeding, and genotyping errors in genetic 
association studies, the Hardy-Weinberg equilibrium (HWE) test is employed. HWE was 
used to test whether all ASTN and RELN markers under investigation conformed to Hardy-
Weinberg expectations. Based on the results presented in tables 3.4 and 3.5, all P-values 
were above 0.05 indicating that all markers were in HWE. This confirmed that the 
genotyping and sampling procedures were efficient and that it was unlikely that major 
confounding population substructure existed.  
 
4.1.4 The Effect of Small Sample Size 
 
A small sample size results in a low power, which decreases one’s chance of observing an 
association between markers of minor effect and disease susceptibility. With the 
significant genotypic association obtained for rs607755 (P= 0.049) a post-test power 
calculation generated a value of 0.58. Although this is not a poor post-test power value, an 
ideal value would lie between 75-80% to indicate a high chance of one detecting this 
association in a new study using the same sample size. One must therefore bear in mind 
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that it might not be a true positive association as a result of the low post-test power value.  
It is impossible for one to conclude that the other markers are definitely not involved in 
the disease, they might have a subtle role in disease pathogenesis or protection but due to 
the small sample size and therefore lack of adequate statistical power, no association was 
observed. If a gene plays a major role a smaller sample size should still allow one to 
observe it. However, if a gene plays a minor role, it would only be observed with a large 
sample size. 
 
4.1.5 Inferred Associations Between the Markers and Disease Susceptibility 
 
The haplotype analysis revealed that cases and controls do not differ significantly for 
either gene (tables 3.7 and 3.8). ASTN’s global simulated P-value was 0.90 and RELN’s 
was 0.269; neither was below 0.05. The analysis revealed that the GGC haplotype (which 
harboured alleles, rs6413830^G, rs12118933^G and rs2228956^C) was the most common 
haplotype for the ASTN gene as it was present in 68% of controls and 73% of cases. For 
RELN, the most common haplotype was CC (alleles rs362691^C and rs607755^C) with 
56.7% of controls and 65.6% of cases having this haplotype.   
 
The backward stepwise logistic regression analysis revealed that the two RELN SNPs best 
fit the “FAS versus controls” model. The P-value generated from the overall model was 
significant (P= 0.032) which indicates that the entire model significantly distinguishes 
between cases and controls. An independent significant association was seen between 
rs607755’s C/T genotype (P= 0.026) and control subjects thus suggesting it may have a 
minor protective role against FAS.   
 
4.1.6 Interaction Between the Markers 
 
The results generated from the pairwise linkage disequilibrium (LD) tests indicated that 
ASTN’s rs6413830 and rs12118933 were tightly linked. High LD was also seen between 
rs12118933 and rs2228956. Rs6413830 and rs2228956 were in very low LD (figure 3.23). 
When markers are in high LD they are thought to be inherited together and any effect they 
have will be a combined one. However, markers that are situated close together are often 
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in LD due to their proximity, especially in recently admixed populations. The ASTN SNPs 
reported to be in high LD are situated closely together therefore indicating that they could 
possibly be inherited together or the high D’ values are simply due to their proximity to 
one another. The two RELN SNPs were shown to be in moderate LD suggesting the two 
SNPs act independently from one another (figure 3.24). 
 
4.1.7 Decision Not to Correct for Multiple Testing 
 
An issue that could possibly be raised from this genetics study is the absence of correction 
for multiple testing. The topic of correcting for multiple testing in a genetics study is a 
controversial one that has been seriously debated (Benjamini et al.  2001). The major 
concern for studies employing multiple statistical tests is false-positive associations. There 
are several ideas and suggestions as to how and why one should correct for multiple 
testing but there is no single correct method that is appropriate in all situations.  
 
Van den Oord (2005) mentioned that adjustments for multiple testing are rarely seen in 
candidate gene studies where a relatively small number of genetic markers are typed. This 
could be due to genetic researchers being hesitant to correct for multiple testing as it may 
reduce the power of a study and therefore lower the chances of being able to detect any 
associations.  It has also been raised that the methods of correcting for multiple testing are 
inappropriate for genetic studies as genetic markers are often analysed in a variety of ways 
(individually or simultaneously as haplotypes) and therefore tests performed cannot 
always be considered independent (van den Oord, 2005).  
 
Several methods have been used to limit false discoveries such as the Bonferroni 
correction, the sequential Bonferroni (Gordi and Khamis, 2004) and the False Discovery 
Rate (FDR) (Benjamini et al.  2001). One of the most commonly used procedures is the 
Bonferroni correction. The Bonferroni correction involves dividing the α value 
(significance level), usually set at 0.05, by the total number of tests performed. This 
generates a corrected α value that the P-values are compared against to test for any 
significant association. This test has the reputation of being too conservative (Nyholt, 
2001). 
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The problem of false-positives arising is most severe when the various tests are 
independent as opposed to being correlated. Correlated tests are less likely to form false 
discoveries. If markers are in significant LD with one another, their association results 
with the disease will be correlated. It has been suggested that where significant LD exists 
between markers it is possibly better to just report the disease-marker association results 
without correction and then state the LD association between the markers (Nyholt, 2001). 
 
For this FAS genetics study involving ASTN and RELN markers, correction for multiple 
testing was not performed for the following reasons. Firstly, there is no definite correcting 
procedure that has been universally accepted and utilised in the field of Human Genetics 
for these types of studies. Secondly, correction for multiple testing considers independent 
variables as the number of tests; this study involved both independent and dependent 
variables. ASTN’s rs6413830 and rs12118933 were considered to be in high LD and so 
were markers rs12118933 and rs2228956 (figure 3.1). However, not all markers of this 
study were in LD with one another, which resulted in some independent and some 
correlated variables being present.  
 
Thirdly, if one were to ignore the possible correlated variables and count individual tests 
for this study, the number would be enormous considering the various statistical analyses 
that were conducted. A large number of tests would result in an inconsequential α and true 
associations with factors that make a minor contribution to the phenotype may be missed. 
A fourth and final reason for not correcting for multiple testing in this study was the fact 
that the candidate genes were not randomly chosen, they were selected based on their 
appropriateness for this particular study. One would expect a higher number of spurious 
associations to be seen between a disease and randomly selected genes. However, ASTN 
and RELN play a definite role in the neuronal migration pathway and were selected based 
on the phenotypic similarities seen between animal models when these genes or gene 
regions are mutated and FAS individuals. The likelihood of finding a true association 
would therefore be high. 
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4.2        PROJECT LIMITATIONS 
 
Like most research investigations this study had its limitations. A confounding factor to 
this study might be alcoholism itself. The reason for this is that children inherit half their 
genes from their mothers and there is a high likelihood that mothers of FAS children are 
alcoholics. One could therefore be detecting genes associated with alcoholism instead of 
those associated with susceptibility to FAS. 
 
The greatest limiting factor was the small sample size and consequent lack of adequate 
power. FAS is prevalent in relatively isolated, rural areas of the Northern Cape and so 
collecting case samples is dependent upon several logistical factors. Diagnosing FAS 
individuals does not happen on a continuous basis. The trained medical team from FARR 
and Johannesburg’s Department of Human Genetics attend the Northern Cape clinics once 
a month for about five days at a time.   
 
Collection of FAS samples is therefore highly dependent upon a number of people 
including the professionals responsible for making a positive diagnosis and those in 
charge of obtaining informed consent and taking blood samples. In addition to that, the 
lengthy assessment necessary for confirming or ruling out a FAS diagnosis in an 
individual allows only a few patients to be seen per visit. The turn-around time from 
diagnosis to collection of a blood sample to receiving the sample in Johannesburg is 
relatively slow and limits the number of case subjects obtained. A larger sample size 
would increase the power of the study and heighten the chances of one observing an 
association between a marker of a gene that might only have a subtle effect on the 
susceptibility for FAS. 
 
Another problem observed was the method of SNP detection. This study pointed out how 
not all information presented on genetics/bioinformatics databases is valid. Selecting and 
analysing SNPs that have not been verified with frequency data can often be a costly 
waste of time.  
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The final limiting factor is the actual time taken to analyse a small number of SNPs in 
candidate genes. Genotyping SNPs manually in a low throughput laboratory as described 
previously is a lengthy process and therefore limits the number of candidate genes and 
markers one can investigate per study. In high throughput laboratories thousands of SNPs 
can be typed in one day due to the automated process that is carried out by costly 
equipment.  
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CHAPTER 5: CONCLUSION AND FUTURE PROSPECTS 
 
This FAS genetics study involving ASTN and RELN yielded only one significant 
genotypic association between RELN’s rs607755 and FAS. The logistic regression model 
supported this by indicating that the heterozygous state of rs607755 (C/T) was more likely 
to be associated with control individuals thus inferring a possible protective effect against 
the disease. One of the limitations of this study was the lack of adequate power related to 
the small sample size, due to this one cannot completely rule out any possible role of 
ASTN and the other RELN marker or other closely linked genetic variants in disease 
susceptibility.  
 
Regarding the frequency results generated for the SNPs in the control group of the 
Northern Cape Coloured population, these will be submitted to Ensembl along side the 
frequencies for the African American and European populations. These would be good 
comparative data representing a truly admixed population and confirming the 
polymorphic nature of the SNPs. 
 
For future studies a more efficient SNP selection method should be employed to prevent 
uninformative SNPs from being examined in the laboratory. Information from the 
HapMap project may be considered for future work but used with caution in populations 
that have not yet been studied. The International HapMap Project was initiated with the 
aim of constructing a public database of common variation in the human genome and was 
launched in 2002. The first phase of the project has just been completed; over one million 
SNPs in 269 DNA samples from four different populations have been recorded (The 
International HapMap Consortium, 2005). In essence the project aims to map the 
“structure of allelic associations” present in the human genome (McVean et al.  2005). 
The HapMap database (http:www/hapmap.org) indicates haplotype blocks and SNPs that 
are in high LD with one another. This information will be useful for candidate gene 
studies as researchers will be able to select SNPs with good coverage across the candidate 
genes. Also, the information presented in the HapMap database has been confirmed and so 
it is unlikely for researchers to choose uninformative SNPs for their investigations but, as 
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mentioned above, this information should be used with caution as only a few populations 
have been typed. 
 
In order to improve future FAS genetics studies researchers should consider the fine 
categorisation of case individuals into more stringent phenotype groups. FAS diagnosis is 
dependent upon the presence of the typical diagnostic features listed in table 1.1; however, 
the degree of severity in each case individual can vary. It might be of considerable value 
to divide cases into different categories based on the measurements taken to confirm a 
diagnosis. In addition to that, cases that present with other anomalies that are not always 
associated with FAS such as the cardiac and skeletal defects should be categorised 
separately. As described previously, complex disorders like FAS arise due to the 
collective effect of a number of susceptibility DNA variants interacting together with the 
environment. Some genetic variants are likely to have a very subtle role in disease 
pathogenesis and so the more stringent grouping of cases, based on their phenotype, could 
be useful for detection of associations within genes of small effect.  
 
Genes in the neuronal migration pathway remain an excellent choice of candidate genes to 
investigate in FAS. There are many other genes, besides ASTN and RELN, from which 
investigators could select additional candidates. One suggestion could be to look at 
polymorphisms present the receptors of ASTN and RELN. Despite not finding a highly 
significant association between the genes and FAS, ASTN and RELN should be 
investigated further in a FAS genetics study focussing on neuronal migration. Once 
several more samples from the same population have been collected the current study 
should be extended. It is possible that with an increased sample size and increased power, 
more associations could be found between ASTN, RELN and FAS. Due to not correcting 
for multiple testing in this study, repeating the investigation and seeing whether or not the 
same association between RELN’s rs607755 materialises could point towards the original 
finding as being either a true association or a false-positive.  
 
Candidate-gene studies involving complex diseases are far more complicated than those 
involving Mendelian diseases and are therefore still in their infancy. The study under 
review emphasises the difficulties in conducting a genetics study on a complex disorder. 
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Together with the availability of more accurate human genetic information (such as the 
HapMap), researchers should take into account the outcomes and limitations of small 
genetic studies and use them to develop better means of candidate gene selection and 
investigation. Improved bioinformatical methodology possibly involving text mining and 
the linking of terms associated with the disease and specific genes, could minimise the 
number of candidate gene choices and assist in selecting reputable candidate genes for 
case-control studies involving complex diseases. 
 
With regards to FAS in particular, prevention is undoubtedly the best cure. If a mother 
abstains from alcohol during her pregnancy the risk of producing a FAS child or a child 
affected by any other FASD condition is zero. However, the importance of studies such as 
the one discussed in this dissertation lies in the understanding of the molecular basis 
behind the disease. A better understanding of FAS at the molecular and cellular level 
could aid researchers in developing strategies to minimise the effects of the disease and 
possibly protect the unborn child from the severity of alcohol’s teratogenicity through 
supplements, much like folic acid protects against neural tube defects. In addition to that, 
pinpointing genetic markers could allow for the development of a set of genetic tests as 
markers for the disease in the future. 
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APPENDIX B 
 
SNP DIAGRAMS AND GENOTYPING RESULTS 
 
 
 
• All recorded SNPs in the ASTN and RELN genes 
 
 
The schematic illustration below (figure B1) is the legend for figures B2 and B3. It 
explains what the different colours and symbols represent. 
 
 
 
 
Figure B1: Diagrammatic legend explaining Ensembl’s annotated gene diagrams. 
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• Genotyping Data Generated 
 
Table B1: Genotyping data generated for the ASTN and RELN SNPs investigated 
Code 
 
Sex 
 
Case / 
Control 
ASTN  
rs6413830 
ASTN  
rs12118933 
ASTN  
rs2228956 
RELN  
rs362691 
RELN  
rs607755 
NPC 001 F Control G/G G/G C/C C/C T/C 
NPC 003 M Control G/A G/G C/C C/G T/C 
NPC 004 M Control A/A G/G C/C C/C T/T 
NPC 005 F Control A/A G/G C/C C/C C/C 
NPC 006 F Control G/G G/G T/C C/C T/C 
NPC 007 F Control G/G G/G C/C C/C T/C 
NPC 008 M Control A/A G/G C/C C/C T/C 
NPC 009 F Control G/G G/G C/C C/C T/C 
NPC 010 M Control G/A G/G C/C C/C T/C 
NPC 011 F Control G/G G/C C/C C/C C/C 
NPC 012 F Control G/G G/G C/C C/C T/C 
NPC 013 F Control G/G G/G C/C C/C C/C 
NPC 014 F Control G/G G/G C/C C/C T/C 
NPC 015 M Control G/G G/G C/C C/C T/C 
NPC 017 F Control G/A G/G C/C C/C T/C 
NPC 018 F Control G/G G/G C/C C/C T/C 
NPC 019 M Control G/G G/G T/C C/C T/T 
NPC 021 F Control G/A G/G T/C C/C T/C 
NPC 022 M Control G/A G/G C/C C/C T/T 
NPC 023 M Control G/G G/G C/C C/C C/C 
NPC 024 F Control G/G G/G C/C C/G T/T 
NPC 025 M Control G/A G/G C/C C/C T/C 
NPC 026 F Control G/G G/G C/C C/C T/C 
NPC 027 F Control G/A G/G C/C C/C C/C 
NPC 028 F Control A/A G/G C/C C/C T/T 
NPC 029 F Control G/G G/G T/T  C/C T/C 
NPC 030 F Control G/G G/G C/C C/C C/C 
NPC 031 F Control G/A G/G C/C C/C T/C 
NPC 032 M Control G/G G/G C/C C/C T/C 
NPC 033 M Control G/G G/G C/C C/C T/T 
NPC 034 F Control G/A G/G T/C C/C T/C 
NPC 035 M Control G/G G/G C/C C/C T/C 
NPC 036 F Control G/G G/G C/C C/C C/C 
NPC 037 F Control G/G G/G C/C C/C C/C 
NPC 038 F Control G/G G/G C/C C/C C/C 
NPC 039 F Control G/A G/G C/C C/C C/C 
NPC 040 F Control G/G G/C C/C C/C T/C 
NPC 041 F Control G/G G/G C/C C/C T/C 
NPC 042 M Control G/G G/G T/C C/C T/C 
NPC 043 M Control G/G G/G C/C C/C T/C 
NPC 044 F Control G/A G/G C/C C/C C/C 
NPC 045 F Control G/A G/G C/C C/C T/C 
NPC 046 M Control G/G G/G C/C C/C T/C 
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NPC 048 M Control G/G G/G C/C C/C T/C 
NPC 049 M Control G/G G/G C/C C/C T/C 
NPC 050 M Control G/G G/G C/C C/G C/C 
NPC 051 F Control G/G G/G C/C C/C T/T 
NPC 052 F Control G/G G/G C/C C/C C/C 
NPC 053 M Control G/A G/G C/C C/G T/T 
NPC 054 M Control G/A G/G C/C C/C T/C 
NPC 055 M Control A/A G/G C/C C/C T/C 
NPC 056 F Control G/G G/G C/C C/C T/T 
NPC 057 F Control G/A G/G T/C C/C T/C 
NPC 058 F Control G/A G/G C/C C/C T/C 
NPC 059 F Control G/A G/G T/C C/C T/C 
NPC 060 F Control G/G G/G T/C C/C T/C 
NPC 061 M Control G/A G/G C/C C/C C/C 
NPC 062 F Control G/A G/G T/T  C/C C/C 
NPC 063 F Control G/A G/G C/C C/C C/C 
NPC 064 M Control G/G G/G C/C C/G T/C 
NPC 065 F Control G/G G/G C/C C/G T/C 
NPC 066 F Control G/G G/G C/C C/G T/C 
NPC 067 M Control G/G G/G T/C C/G T/C 
NPC 068 M Control G/A G/G C/C C/C T/C 
NPC 069 M Control G/G G/G C/C C/C T/T 
NPC 070 F Control G/G G/G T/C C/C C/C 
NPC 071 M Control G/G G/G C/C C/G C/C 
NPC 072 M Control G/A G/G C/C C/C T/T 
NPC 073 M Control G/A G/G T/C C/C T/C 
NPC 074 M Control G/G G/C C/C C/C T/T 
NPC 075 F Control G/G G/G C/C C/C T/T 
NPC 077 M Control G/G G/G C/C C/C C/C 
NPC 079 M Control G/G G/G C/C C/C C/C 
NPC 080 M Control G/A G/G C/C C/C T/C 
NPC 081 F Control G/G G/G C/C C/C C/C 
NPC 082 F Control G/G G/G C/C C/C C/C 
NPC 083 F Control G/A G/G C/C C/C C/C 
NPC 084 F Control G/G G/G T/C C/C C/C 
NPC 085 F Control G/G G/G C/C C/C C/C 
NPC 086 M Control G/A G/G C/C C/C T/C 
NPC 087 F Control G/A G/G T/C C/C T/C 
NPC 088 F Control G/G G/G C/C C/C T/C 
NPC 089 F Control G/A G/G C/C C/C C/C 
NPC 090 M Control G/G G/G C/C C/C T/C 
NPC 091 M Control G/G G/G C/C C/C C/C 
NPC 092 M Control G/G G/G C/C C/C C/C 
NPC 093 F Control G/A G/G C/C C/C C/C 
NPC 094 F Control G/A G/G T/C C/C T/C 
NPC 095 M Control G/G G/G C/C C/C C/C 
NPC 096 M Control G/G G/G C/C C/C T/C 
NPC 097 F Control G/G G/G C/C C/C T/C 
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NPC 098 F Control G/G G/G C/C C/C T/C 
NPC 099 F Control G/G G/G C/C C/C C/C 
NPC 100 F Control G/G G/G C/C C/C T/C 
NPC 101 M Control G/G G/G C/C C/C T/C 
NPC 102 M Control G/G G/G C/C C/C T/C 
NPC 103 M Control G/A G/G C/C C/C C/C 
NPC 104 M Control A/A G/G C/C C/C T/C 
NPC 105 M Control G/A G/G C/C C/C T/T 
NPC 106 M Control G/G G/G C/C C/C C/C 
NPC 107 M Control G/G G/G T/C C/G T/C 
NPC 108 F Control G/A G/G C/C C/C T/C 
NPC 110 M Control G/A G/G C/C C/C T/T 
NPC 111 M Control G/A G/G C/C C/C T/T 
NPC 112 M Control G/A G/G C/C C/C T/C 
NPC 113 M Control G/A G/G C/C C/C T/C 
NPC 114 M Control G/G G/G C/C C/C T/C 
NPC 115 F Control G/A G/G C/C C/G T/C 
NPC 116 M Control G/G G/G C/C C/C T/C 
NPC 117 M Control G/G G/G T/C C/C T/C 
NPC 118 M Control G/A G/G T/C C/C C/C 
NPC 119 M Control G/A G/G C/C C/C C/C 
        
NPF 001 F Index case A/A G/G C/C C/C T/T 
NPF 010 M Index case G/G G/G C/C C/C C/C 
NPF 013 M Index case G/G G/G C/C C/C T/C 
NPF 017 M Index case G/G G/C C/C C/C C/C 
NPF 018 F Index case G/A G/G T/C C/C C/C 
NPF 022 F Index case G/A G/G C/C C/C C/C 
NPF 024 F Index case G/G G/G C/C C/C T/C 
NPF 026 M Index case G/G G/G C/C C/C T/C 
NPF 028 F Index case G/A G/G C/C C/C C/C 
NPF 031 M Index case G/A G/G C/C C/C C/C 
NPF 034 M Index case G/G G/G C/C C/C T/C 
NPF 036 M Index case G/A G/G C/C C/C T/C 
NPF 038 M Index case G/G G/G C/C C/C C/C 
NPF 042 M Index case G/G G/G T/C C/C C/C 
NPF 044 F Index case G/G G/G T/C C/C T/C 
NPF 045 M Index case G/G G/G C/C C/C T/T 
NPF 047 F Index case G/G G/G C/C C/C C/C 
NPF 049 F Index case G/G G/G C/C C/C T/T 
NPF 053 M Index case G/G G/G C/C C/C C/C 
NPF 054 F Index case G/A G/G C/C C/C C/C 
NPF 059 F Index case G/A G/G C/C C/C C/C 
NPF 060 M Index case G/A G/G T/C C/C T/T 
NPF 062 M Index case G/A G/G C/C C/C T/C 
NPF 065 M Index case G/G G/G C/C C/C T/C 
NPF 066 F Index case G/G G/G C/C C/C C/C 
NPF 069 F Index case G/G G/G T/C C/C C/C 
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NPF 072 F Index case G/G G/C T/C C/C T/T 
NPF 078 F Index case G/G G/G C/C C/C T/C 
NPF 082 M Index case G/G G/G C/C C/C T/T 
NPF 083 F Index case G/G G/G C/C C/C T/T 
NPF 085 M Index case G/A G/G C/C C/C C/C 
NPF 086 F Index case G/G G/G C/C C/C C/C 
NPF 089 F Index case G/G G/G T/C C/G T/T 
NPF 091 F Index case G/A G/G T/C C/C C/C 
NPF 093 M Index case G/A G/G C/C C/C T/C 
NPF 094 F Index case G/G G/G C/C C/C T/C 
NPF 095 M Index case G/A G/G C/C C/C C/C 
NPF 098 M Index case G/G G/G C/C C/C C/C 
NPF 099 F Index case G/G G/G C/C C/C C/C 
NPF 102 F Index case G/G G/G C/C C/C C/C 
NPF 104 F Index case G/G G/G C/C C/C T/C 
NPF 106 F Index case G/A G/G C/C C/C T/C 
NPF 108 F Index case G/G G/G C/C C/C C/C 
NPF 110 M Index case G/G G/G C/C C/C T/C 
NPF 112 M Index case G/A G/G C/C C/C T/C 
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APPENDIX C 
 
DNA LADDERS AND PROTOCOLS 
 
1) DNA Ladders used (Band sizes shown on agarose gels in base pairs)  
 
 
 
 
 
 
HyperLadder V (Bioline) 1 KB Plus DNA Ladder (Invitrogen) 
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2) Flexigene DNA Extraction Kit Protocol  
 
• Reagents required per 8 ml blood sample: 
 
Reagent Volume (ml) 
Buffer FG1 20.0 
Buffer FG2/ protease 4.0 
100% isopropanol 4.0 
70% ethanol 4.0 
Buffer FG3 0.8 
 
• Reagent Preparation: 
 
i. Qiagen protease 
- resuspend protease in 1.4 ml Buffer FG3 
 
ii. FG2/Qiagen protease mix 
- to be prepared an hour before extraction 
- 4 ml FG2 and 40 µl protease 
 
• Protocol: 
 
-   Add 20 ml buffer FG1 into a 50 ml NUNC tube 
-   Add 8 ml whole blood and invert 5 times 
-   Centrifuge for 5 minutes at 3000 rpm 
-   Discard the supernatant and invert the tube on paper for 2 minutes 
-   Add 4 ml FG2/protease and vortex until completely homogenised 
-   If traces of jelly-like consistency are still visible add 1 ml FG2 and vortex again 
-   Invert tube 3 times 
-   Incubate at 650C for 10 minutes  
-   Colour change from red to olive green should occur indicating complete protein     
    digestion, leave for longer if colour change does not occur 
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-   Add 4 ml 100% isopropanol and mix thoroughly by inversion until DNA becomes       
    visible in threads 
-   Centrifuge for 3–5 minutes at 3000 rpm 
-   Discard the supernatant and invert the tube on paper for 2 minutes 
-   Add 4 ml 70% ethanol and vortex for 5 seconds 
-   Centrifuge for 3-5 minutes at 3000 rpm 
-   Discard the supernatant and invert the tube on paper for 2 minutes 
-   Air-dry the pellet for about 5 minutes 
-   Add 0.8 ml FG3 and vortex for 5 seconds at low speed 
-   Incubate for 1 hour at 650C or overnight at room temperature 
 
 
3) PCR reagents for a standard PCR reaction 
 
Reagent Volume (µl) 
DNA (100 ng/µl) 1.0 
AmpliTaq Gold ( 5 units/µl; Applied Biosystems, Roche) 0.2 
10x PCR Gold Buffer (Applied Biosystems, Roche) 2.5 
MgCl2  (25 mM; Applied Biosystems, Roche) 2.0 
dNTP mix (1.25 mM; see Appendix D) 2.5 
Forward primer (10 µM; see Appendix D for primer dilutions) 1.0 
Reverse primer (10 µM; see Appendix D for primer dilutions) 1.0 
ddH20 14.8 
Total 25.0 
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4) PCR reagents for the ARMS PCR reaction (rs362691) 
 
Reagent Volume (µl) 
DNA (100 ng/µl) 1.0 
AmpliTaq Gold (5 units/µl; Applied Biosystems, Roche) 0.2 
10x PCR Gold Buffer (Applied Biosystems, Roche) 2.5 
MgCl2 (25 mM; Applied Biosystems, Roche) 2.0 
dNTP mix (1.25 mM; see Appendix D) 2.5 
Forward primer (either detecting the “mutant” or “wild-type” allele) 
(10 µM; see Appendix D for primer dilutions) 
1.0 
Reverse primer (10 µM; see Appendix D for primer dilutions) 1.0 
Control Forward primer (10 µM; see Appendix D for primer dilutions) 1.0 
Control Reverse primer (10 µM; see Appendix D for primer dilutions) 1.0 
Spermidine (1/40 dilution of a 0.1 M stock; see Appendix D)  2.5 
ddH20 10.3 
Total 25.0 
 
 
5)      PCR product clean-up using the NucleoSpin® Extract II kit (Macherey-Nagel) 
 
- Adjust PCR product’s volume to 50 µl with TE buffer (pH=7.5) (30 µl TE + 20 µl 
PCR product) 
- Mix 2 volumes of NT buffer with 1 volume of PCR product (i.e. 100 µl NT +      
50 µl PCR product) 
- Place column in collection tube and load sample onto column 
- Centrifuge for 1 minute at 14 000 rpm 
- Discard flow-through and place column back into collection tube 
- Pipette 600 µl NT3 buffer onto column 
- Centrifuge for 1 minute at 14 000 rpm 
- Discard flow-through and place column back in to collection tube 
- Centrifuge for 2 minutes at 14 000 rpm 
- Discard flow-through 
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- Incubate columns for 2-5 minutes at 700C with the caps open  
- Place columns into clean Eppendorf tubes 
- Pipette 20 µl ddH20 (volume must be equal to starting volume) 
- Incubate samples for 1 minute at room temperature 
- Centrifuge for 1 minute at 14 000 rpm 
- Discard column 
 
6) Cycle sequencing PCR reagents 
 
Reagent Volume (µl) 
Cleaned PCR product 6 
BigDye Terminator v3.1 (Applied Biosystems) 4 
BigDye Terminator v3.1 5X sequencing buffer (Applied 
Biosystems) 
2 
Primer (forward or reverse; 10 µM; see Appendix D for dilutions) 1 
ddH20 7 
Total 20 
 
 
• Cycle Sequencing Parameters 
 
Denaturation  960C  30 secs 
Annealing   500C  15 secs 
Extension   600C  4 mins 
Hold   40C  ∞ 
   
 
 
 
 
 
 
25 cycles 
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7) Cycle sequencing product clean-up using the Qiagen DyeEx 2.0 spin kit 
 
- Gently vortex each spin column to remove air bubbles 
- Slightly loosen the column cap and snap off the bottom of each column tube 
- Place column in a collection tube 
- Centrifuge for 3 minutes at 3000 rpm 
- Discard flow-through and place column in a clean collection tube 
- Load entire cycle sequencing product onto the middle of the column 
- Centrifuge for 3 minutes at 3000 rpm 
- Discard column 
 
Sample was then vacuum dried for 1 hour in the 5301 Concentrator (vacuum dryer) 
manufactured by Eppendorf. 
 
8) Preparation for the ABI 3130 Genetic Analyzer 
 
      -    Add 10 µl HiDi Formamide (Applied Biosystems) to each vacuum dried sample 
      -    Load products into a 96-well sequencing plate 
      - Place plate in a 2720 thermal cycler for 2 minutes to denature the DNA 
      - Place plate on ice 
      - Load plate into the 3130 Genetic Analyzer (Applied Biosystems) 
- Select Z_Seq_POP7_36_UltraSeq for sequences less than 500 bp or   
      Z_Seq_POP7_36_RapidSeq for longer sequences 
- Select analysis protocol 3130pop7_BDTV3_kb 
- Follow the prompts on the screen and enter the identity of each product in each  
well. Sequencing can then begin 
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APPENDIX D 
 
REAGENTS 
 
dNTP mix (Bioline) 
A 1 ml working solution containing 1.25 mM of each dNTP was made as follows: 
 
0.5 M EDTA (pH 8.0) 
93.06 g EDTA dihydrate (Research Organics) 
100 ml  ddH20  
pH to 8 with 5 M NaOH pellets (SMM Chemicals)  
 
Ficoll dye 
25 g sucrose (Invitrogen Life Technologies) 
5 ml 0.5 M EDTA 
0.05 g bromophenol blue (Merck) 
5 g Ficoll (Sigma-Aldrich) 
Add ddH20 to make a total volume of 50 ml 
 
1 Kb Plus DNA ladder 
250 µl 1 Kb Plus ladder (Invitrogen Life Technologies) 
125 µl Ficoll dye (Sigma-Aldrich) 
2.1 ml TE buffer 
 
 
12.5 µl of 100 mM dATP + 112.5 µl ddH20  
12.5 µl of 100 mM dCTP + 112.5 µl ddH20 
12.5 µl of 100 mM dGTP + 112.5 µl ddH20                         
12.5 µl of 100 mM dTTP + 112.5 µl ddH20                                  
Mix together and 
add 500 µl ddH20 
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Primer dilutions 
All primers were resuspended in a certain volume of ddH20 as stated by the manufacturer 
(Inqaba Biotech) to form 100 µM stock solutions. 1 in 10 dilutions (10 µM) of each 
primer were made for PCR reactions: 
- 10 µl of primer stock (100 µM) 
- 90 µl ddH20 
- All primer stocks and dilutions were stored at –200C 
 
Spermidine 
The following protocol was used to make a 0.1 M stock solution: 
1 g spermidine (254.63 g/mol; Merck) 
40 ml  ddH20 
 
1 in 40 Spermidine dilution 
1 µl of a 0.1 M spermidine stock solution 
39 µl ddH20 
 
10 x TBE buffer 
432 g Tris (Roche) 
220 g Boric acid (Promega) 
29.7 g EDTA dihydrate (Research Organics) 
Add ddH20 and make up to a final volume of 4 l 
Autoclave before use 
 
1M Tris-HCl 
12.11 g    Tris (Roche) 
pH to 8.0 and make up to 100 ml with ddH20 
 
1 x TE buffer (pH 7.5) 
1 ml 1 M Tris-HCl 
200 µl 0.5 M EDTA  
Make up to 100 ml with ddH20 
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3% Agarose gel 
12 g Agarose (Hispanagar) 
400 ml 1x TBE buffer 
Heat in the microwave until fully dissolved 
Once slightly cooled, add 12 µl of a 10 mg/µl ethidium bromide stock (Sigma) 
Pour the gel mix into a gel tray 
 
 
4% Agarose gel 
16 g Agarose (Hispanagar) 
400 ml 1x TBE buffer 
Heat in the microwave until fully dissolved 
Once slightly cooled, add 12 µl of a 10 mg/µl ethidium bromide stock (Sigma) 
Pour the gel mix into a gel tray 
 
 
